Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 10-Q/A
Amendment No. 110-Q
______________________
(Mark One)
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended SeptemberJune 30, 20212022
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
______________________
Hyzon Motors Inc.
(Exact name of registrant as specified in its charter)
______________________
Delaware001-3963282-2726724
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
475 Quaker Meeting House Road
Honeoye Falls, NY
14472
(Address of principal executive offices)(Zip Code)

(585)-484-9337
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
______________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Common Stock, par value $0.0001 per shareHYZNNasdaqNASDAQ Capital Market
Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per shareHYZNWNasdaqNASDAQ Capital Market
______________________
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  o    No x
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  o    No  x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated fileroAccelerated filero
    
Non-accelerated filerxSmaller reporting companyx
    
Emerging growth companyx
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  o    No  x

As of March 1,31, 2023, 244,559,301244,561,073 shares of Class A Common Stock, par value $0.0001 per share, were issued and outstanding.

1

Table of Contents
EXPLANATORYCAUTIONARY NOTE REGARDING FORWARD- LOOKING STATEMENTS

Hyzon Motors Inc. (“Hyzon”, the “Company”, “we”, “our” or “us”) filed ourThis Quarterly Report on Form 10-Q forcontains forward-looking statements within the quarterly period ended September 30, 2021 (the “Original Filing”) withmeaning of the Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Commission ("SEC"Act of 1934, as amended (the “Exchange Act”). These statements include, without limitation, statements regarding the financial position, business strategy, plans and objectives of management for future operations, and any statements that refer to characterizations of future events or circumstances, including any underlying assumptions. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this report, the words “could,” “should”, “will,” “may,” “anticipate,” “believe,” “expect,” “estimate,” “intend,” “plan,” “project,” the negative of such terms, and other similar expressions are intended to identify forward looking statements, although not all forward-looking statements contain such identifying words. Such forward-looking statements are based on November 15, 2021. This Amendment No. 1management’s current expectations and assumptions about future events and are based on Form 10-Q/A (this "Form 10-Q/A") is being filedcurrently available information as to amendthe outcome and restate certain items contained in the Original Filing (the "Restatement").timing of future events.

Restatement Background

As previously reported inForward-looking statements are subject to a number of risks and uncertainties including, but not limited to, those described below and under the Company's Current Report on Form 8-K filed with the SEC on August 17, 2022, the Audit Committee of the Board of Directors (the “Board”) of the Company (the "Audit Committee"), based on the recommendation of management, determined that the Company's previously issued financial statementssection entitled “Risk Factors” included in the Company’sour Annual Report filed on Form 10-K for the year ended December 31, 2021, as amended by Amendment No. 1 on Form 10-K/A filed with the Securities and Exchange Commission (“SEC”) on March 14, 2023, and in subsequent reports that we file with the Company’s previously issued financial statements included in the Company’s Quarterly Report onSEC, including this Form 10-Q for the period ended March 31, 2022 should no longer be relied upon and require restatement because of issues regarding revenue recognition and internal controls and procedures, primarily pertaining to our China operations.

As further previously reported in the Company's Current Report on Form 8-K filed with the SEC on February 9, 2023, the Audit Committee, based on the recommendation of management, determined that the Company’s previously issued financial statements included in the Company’s Original Filing should no longer be relied upon and also require restatement primarily because of issues regarding revenue recognition relating to its European joint venture operations.

For a more detailed discussion of the Restatement, refer to Note 2. Restatement of Previously Issued Financial Statements to the condensed consolidated financial statements of the Company included herein.

Special Committee Investigation

As previously reported in the Company's Current Report on Form 8-K filed with the SEC on August 4, 2022, in connection with the preparation of the Company's financial results for the periodquarter ended June 30, 2022, the Board appointed a committee of Board members (the "Special Committee")2022:
our ability to investigate,commercialize our products and strategic plans, including our ability to establish facilities to produce our vehicles or secure hydrogen supply in appropriate volumes, at competitive costs or with the assistance of outside counsel and other advisors, the issues described above regarding revenue recognition and internal controls and procedures that were brought to the attention of the Board by management (the "Investigation"). The preliminary findings of the Investigation were completed in January 2023, and the final findings were issued in March 2023 as discussed in this Explanatory Note below.

competitive emissions profiles;
Investigation with Respect to China Operations

On January 12, 2022, the Company announced the delivery of 87 fuel cell powered heavy-duty vehicles in 2021, which included 82 vehicles delivered to customers in China. In July 2022, management discovered and brought to the attention of the Board that certain vehicles may not have met the criteria necessary to recognize revenue as of December 31, 2021. The Special Committee was formed to conduct an investigation regarding the Company’s revenue recognition timing and internal controls and procedures, primarily pertaining to the Company’s China operations during the second half of 2021 and the first half of 2022.

Based on the Investigation's findings, the Company concluded that the Company's contractual performance obligationour ability to deliver functioning fuel cell electric vehicles (“FCEVs”) was not fully satisfied for revenue recognition purposes under Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers ("ASC 606"). Correction of the errors is reflectedeffectively compete in the restated annual financial statements for the year ended December 31, 2021 includedheavy-duty transportation sector, and withstand intense competition and competitive pressures from other companies worldwide in the Company’s amended Annual Report on Form 10-K/A and the interim financial statements for the period ended March 31, 2022 includedindustries in the Company's amended Quarterly Report on Form 10-Q/A.which we operate;

Investigationour ability to convert non-binding memoranda of understanding and letters of intent into binding orders or sales (including because of current or prospective resources of our counterparties) and the ability of our counterparties to make payments on orders;

our ability to invest in hydrogen production, distribution, and refueling operations to supply our customers with Respecthydrogen at competitive costs to European Operationsoperate their fuel cell electric vehicles;

disruptions to the global supply chain, including as a result of the COVID-19 pandemic, the war in Ukraine and geopolitical events, and shortage of raw materials, and the related impacts on our third party suppliers and assemblers;

our ability to maintain the listing of our common stock on NASDAQ;

our ability to raise financing in the future;

our ability to retain or recruit, or changes required in, our officers, key employees or directors;

cybersecurity threats and breaches and compliance with privacy and data protection laws;

our ability to protect, defend, or enforce intellectual property on which we depend; and

the impacts of legal proceedings, regulatory disputes and governmental inquiries.

Should one or more of the risks or uncertainties described above, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements.

The Special Committee identified certain issues associated with Hyzon Motors Europe B.V. ("Hyzon Europe"), the Company's European joint venture. The Investigation revealed that certain former members of Hyzon Europe's senior management team created a workplace culture where employees did not feel comfortable raising concerns. Additionally, the Investigation revealed that for five vehicles for which Hyzon Europe recognized revenue in 2021, Hyzon Europe subsequently performed various levels of work and repair efforts on such vehicles after revenue had been recognized.

2

Table of Contents
Consequently, the Company conducted an internal accounting review for its European customer arrangements. This internal accounting review concluded that for the Hyzon Europe customer contracts which were assumed from Holthausen Clean Technology B.V. in July 2021, the Company did not appropriately analyze and record revenue and related balances associated with these arrangements.More specifically, the Company determined that instead of manufacturing or assembling FCEVs that it owned for sale to customers, Hyzon Europe was providing these customers with vehicle retrofit services to convert the customers' internal combustion engine ("ICE") powered vehicles to hydrogen FCEVs. Therefore, Hyzon Europe should have recognized revenue over time utilizing an input method rather than recording revenue at a point in time. For additional information regarding the corrections to the financialforward-looking statements refer to Note 2. Restatement of Previously Issued Financial Statements to the condensed consolidated financial statements of the Company included herein. Correction of the errors is also reflected in the restated annual financial statements for the year ended December 31, 2021 included in the Company’s amended Annual Report on Form 10-K/A and the interim financial statements for the period ended March 31, 2022 included in the Company's amended Quarterly Report on Form 10-Q/A.

Transaction Costs

On July 16, 2021, legacy Hyzon Motors Inc. ("Legacy Hyzon") and now named Hyzon Motors USA Inc. consummated the transactions contemplated by the Business Combination Agreement and Plan of Reorganization (the “Business Combination”), dated February 8, 2021, with Decarbonization Plus Acquisition Corporation (“DCRB”) to effect a business combination between DCRB and Legacy Hyzon with DCRB Merger Sub Inc., a wholly owned subsidiary of DCRB, merging with and into Legacy Hyzon, with Legacy Hyzon surviving the merger as a wholly owned subsidiary of DCRB. The Company has adjusted its prior allocation of transaction costs incurred in connection with the Business Combination to reflect the allocation of the correct balance of Company incurred transaction costs between the liability classified earnout arrangement and the newly issued equity instruments in the Business Combination in the third quarter of 2021. The adjustment resulted in a reduction of amounts previously allocated to the earnout liability and recognized as expense, offset by an equal increase of transaction costs allocated to the newly issued equity instruments and recorded against additional paid-in capital. For additional information regarding the corrections to the financial statements, refer to Note 2. Restatement of Previously Issued Financial Statements to the condensed consolidated financial statements of the Company included herein. Correction of the errors is also reflected in the restated annual financial statements for the year ended December 31, 2021 included in the Company’s amended Annual Report on Form 10-K/A and the interim financial statements for the period ended March 31, 2022 included in the Company's amended Quarterly Report on Form 10-Q/A.

Other Immaterial Errors    

In addition to the errors described above, the Company’s previously issued financial statements included in the Company’s Original Filing and the Company's previously issued audited annual financial information included in the Company’s Annual Report on Form 10-K for the period ended December 31, 2021 and for the Company’s previously issued unaudited quarterly financial information included in the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2022, have been corrected in the amended filings to include previously unrecorded immaterial adjustments (the “Other Immaterial Errors”). For additional information regarding the Other Immaterial Errors, refer to Note 2. Restatement of Previously Issued Financial Statements to the condensed consolidated financial statements of the Company included herein.

The errors described above and the Other Immaterial Errorscontained in this amended Quarterly Reportreport are based on Form 10-Q/A did not impact cash or the economics of the Company's existing commercial arrangements.

Internal Control Considerations

In connection with the Restatement, the Company has concluded there were material weaknesses in the Company’s internal control over financial reporting as of September 30, 2021our current expectations and its disclosure controlsbeliefs concerning future developments and procedures were not effective as of September 30, 2021. Management is taking steps to remediate the material weaknesses in our internal control over financial reporting.

For a discussion of management’s consideration of our disclosure controlstheir potential effects on us and procedures, internal control over financial reporting, and the material weaknesses identified, see Part I, Item 4. Controls and Procedures of this Form 10-Q/A.

3

Table of Contents
Items Amended in this Form 10-Q/A

This Form 10-Q/A presents the Original Report, amended and restated with modifications as necessary to reflect the correction of Restatement Items and Other Immaterial Errors. The following items have been amended:
Part I - Item 1. Financial Statements
Part I - Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Part I - Item 4. Controls and Procedures
Part II - Item 1A. Risk Factors
Part II - Item 6. Exhibits

Except as described above and in Note 17. Subsequent Events, this Form 10-Q/A does not amend, update or change any other items or disclosures in the Original Filing and does not purport to reflect any information or events subsequent to the filing thereof. As such, this Form 10-Q/A speaksspeak only as of the date the Original Filing was filed, and the Company has not undertaken hereinof this report. Except as otherwise required by applicable law, we disclaim any duty to amend, supplement, or update any information containedforward looking statements, all of which are expressly qualified by the statements in the Original Filing to give effect to any subsequent events. Among other things, forward-looking statements made in the Original Filing have not been revisedthis section, to reflect events results or developments that occurred or facts that became known to uscircumstances after the date of the Original Filing, other than the Restatement. In addition,this report. You should, however, review additional disclosures we make in accordance with SEC rules, this Form 10-Q/A includes updated certifications from our Chief Executive Officer as Exhibits 31.1 and 32.1dated as of the filing date of this Form 10-Q/A. Accordingly, this Form 10-Q/A should be read in conjunction with oursubsequent filings made with the SEC subsequent to the filing of the Original Filing, including any amendments to those filings.SEC.
42

Table of Contents

Hyzon Motors, Inc.
Quarterly Report on Form 10-Q
Table of Contents
Page No.
53

Table of Contents
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements

HYZON MOTORS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(in thousands, except share and per share amounts)
September 30, 2021December 31, 2020
(As Restated)
ASSETS
Current assets
Cash$498,014 $17,139 
Accounts receivable5,991 — 
Inventory12,691 — 
Prepaid expenses and other current assets24,695 848 
Total current assets541,391 17,987 
Property, plant, and equipment, net8,878 418 
Right-of-use assets7,962 1,656 
Deferred merger transaction costs— 732 
Restricted cash and other assets7,755 212 
Total Assets$565,986 $21,005 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable$2,851 $215 
Accrued professional fees1,003 900 
Other accrued expenses3,205 162 
Related party payables4,554 560 
Horizon IP agreement payable10,000 — 
Contract liabilities7,846 2,608 
Current portion of lease liabilities1,164 618 
Total current liabilities30,623 5,063 
Long term liabilities
Lease liabilities7,111 1,181 
Private placement warrant liability11,781 — 
Earnout liability115,014 — 
Other liabilities316 — 
Total liabilities$164,845 $6,244 
Commitments and contingencies (Note 12)
Stockholders’ Equity
Common stock, $0.0001 par value; 400,000,000 shares authorized, 247,500,505 and 166,125,000 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively.25 17 
Additional paid-in capital400,021 29,122 
Retained earnings (accumulated deficit)2,782 (14,271)
Accumulated other comprehensive loss(327)(16)
Total Hyzon Motors Inc. stockholders’ equity402,501 14,852 
Noncontrolling interest(1,360)(91)
Total Stockholders’ Equity401,141 14,761 
Total Liabilities and Stockholders’ Equity$565,986 $21,005 
(unaudited)
June 30,
2022
December 31,
2021
ASSETS
Current assets
Cash and cash equivalents$363,941 $445,146 
Accounts receivable15 2,956 
Related party receivable22 264 
Inventory40,134 20,927 
Prepaid expenses and other current assets24,490 26,852 
Total current assets428,602 496,145 
Property, plant, and equipment, net21,240 14,346 
Right-of-use assets10,315 10,265 
Investments in equity securities15,030 4,948 
Other assets5,727 4,575 
Total Assets$480,914 $530,279 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable$7,771 $7,980 
Accrued liabilities10,918 6,770 
Related party payables184 3,695 
Contract liabilities2,056 10,925 
Current portion of lease liabilities2,406 1,886 
Total current liabilities23,335 31,256 
Long term liabilities
Lease liabilities8,572 8,830 
Private placement warrant liability5,290 15,228 
Earnout liability34,424 103,761 
Deferred income taxes526 — 
Other liabilities6,155 1,139 
Total liabilities78,302 160,214 
Commitments and contingencies (Note 11)
Stockholders’ Equity
Common stock, $0.0001 par value; 400,000,000 shares authorized, 248,006,857 and 247,758,412 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively.25 25 
Additional paid-in capital403,424 400,826 
Retained earnings (accumulated deficit)9,064 (26,412)
Accumulated other comprehensive (loss) income(140)378 
Total Hyzon Motors Inc. stockholders’ equity412,373 374,817 
Noncontrolling interest(9,761)(4,752)
Total Stockholders’ Equity402,612 370,065 
Total Liabilities and Stockholders’ Equity$480,914 $530,279 

The accompanying notes are an integral part of these unaudited condensedconsolidated financial statements
4

Table of Contents
HYZON MOTORS INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
(in thousands, except per share amounts)
(unaudited)
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Revenue$46 $ $2,934 $ 
Operating expense:
Cost of revenue1,370 — 2,023 — 
Research and development10,483 3,473 17,419 4,099 
Selling, general, and administrative20,065 5,800 39,817 8,946 
Total operating expenses31,918 9,273 59,259 13,045 
Loss from operations(31,872)(9,273)(56,325)(13,045)
Other income (expense):
Change in fair value of private placement warrant liability8,415 — 9,938 — 
Change in fair value of earnout liability66,096 — 69,337 — 
Gain (loss) on equity securities(2,448)— 10,082 — 
Foreign currency exchange loss and other expense(1,454)(30)(2,604)(59)
Interest income (expense), net54 (407)71 (4,995)
Total other income (expense)70,663 (437)86,824 (5,054)
Net income (loss) before income taxes38,791 (9,710)30,499 (18,099)
Income tax expense— — 526 — 
Net income (loss)$38,791 $(9,710)$29,973 $(18,099)
Less: Net loss attributable to noncontrolling interest(3,208)(289)(5,503)(531)
Net income (loss) attributable to Hyzon$41,999 $(9,421)$35,476 $(17,568)
Comprehensive income (loss):
Net income (loss)$38,791 $(9,710)$29,973 $(18,099)
Foreign currency translation adjustment(235)(55)(24)(86)
Comprehensive income (loss)$38,556 $(9,765)$29,949 $(18,185)
Less: Comprehensive loss attributable to noncontrolling interest(2,840)(287)(5,009)(520)
Comprehensive income (loss) attributable to Hyzon$41,396 $(9,478)$34,958 $(17,665)
Net income (loss) per share attributable to Hyzon:
Basic$0.17 $(0.06)$0.14 $(0.11)
Diluted$0.16 $(0.06)$0.14 $(0.11)
Weighted average common shares outstanding:
Basic248,056 166,249 247,999 166,225 
Diluted258,265 166,249 258,772 166,225 

The accompanying notes are an integral part of these unaudited consolidated financial statements.
5

Table of Contents
HYZON MOTORS INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(in thousands, except share data)
(unaudited)
Legacy
Common Stock
Common Stock
Class A
Additional
Paid-in
Capital
Retained
Earnings
(Accumulated
Deficit)
Accumulated
Other
Comprehensive
Income (Loss)
Total Hyzon
Motors Inc.
Stockholders’
Equity (Deficit)
Noncontrolling
Interest
Total
Stockholders’
Equity (Deficit)
SharesAmountSharesAmount
Balance as of December 31, 2021 $ 247,758,412 $25 $400,826 $(26,412)$378 $374,817 $(4,752)$370,065 
Exercise of stock options— — 30,008 — 34 — — 34 — 34 
Stock-based compensation— — — — 1,193 — — 1,193 — 1,193 
Vesting of RSUs— — 64,815 — — — — — — — 
Net share settlement of equity awards— — — — (160)— — (160)— (160)
Common stock issued for the cashless exercise of warrants— — 28,333 — — — — — — — 
Repurchase of warrants— — — — (31)— — (31)— (31)
Net loss attributable to Hyzon— — — — — (6,523)— (6,523)— (6,523)
Net loss attributable to noncontrolling interest— — — — — — — — (2,295)(2,295)
Foreign currency translation income— — — — — — 85 85 126 211 
Balance as of March 31, 2022  247,881,568 25 401,862 (32,935)463 369,415 (6,921)362,494 
Exercise of stock options  5,316 — — — — 
Stock-based compensation  — — 1,859 — — 1,859 — 1,859 
Vesting of RSUs  103,957 — — — — — — — 
Net share settlement of equity awards  — — (303)— — (303)— (303)
Common stock issued for the cashless exercise of warrants  16,016 — — — — — — — 
Net income attributable to Hyzon  — — — 41,999 — 41,999 — 41,999 
Net loss attributable to noncontrolling interest  — — — — — — (3,208)(3,208)
Foreign currency translation income (loss)  — — — — (603)(603)368 (235)
Balance as of June 30, 2022 $ 248,006,857 $25 $403,424 $9,064 $(140)$412,373 $(9,761)$402,612 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

HYZON MOTORS INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(in thousands, except share data)
(unaudited)
Legacy
Common Stock
Common Stock
Class A
Additional
Paid-in
Capital
Retained
Earnings
(Accumulated
Deficit)
Accumulated
Other
Comprehensive
Loss
Total Hyzon
Motors Inc.
Stockholders’
Equity (Deficit)
Noncontrolling
Interest
Total
Stockholders’
Equity (Deficit)
SharesAmountSharesAmount
Balance as of December 31, 202093,750,000 $94  $ $29,045 $(14,271)$(16)$14,852 $(91)$14,761 
Retroactive application of recapitalization(93,750,000)(94)166,125,000 17 77 — — — — — 
Adjusted balance, beginning of period  166,125,000 17 29,122 (14,271)(16)14,852 (91)14,761 
Exercise of stock options— — 115,189 — 187 — — 187 — 187 
Stock-based compensation  — — 290 — — 290 — 290 
IP transaction - deemed distribution  — — (10,000)— — (10,000)— (10,000)
Net loss attributable to Hyzon  — — — (8,147)— (8,147)— (8,147)
Net loss attributable to noncontrolling interest  — — — — — — (242)(242)
Foreign currency translation income (loss)  — — — — (38)(38)(29)
Balance at March 31, 2021  166,240,189 17 19,599 (22,418)(54)(2,856)(324)(3,180)
Exercise of stock options  17,711 — — — — 
Stock-based compensation  — — 526 — — 526 — 526 
Net loss attributable to Hyzon  — — — (9,421)— (9,421)— (9,421)
Net loss attributable to noncontrolling interest  — — — — — — (289)(289)
Foreign currency translation income (loss)  — — — — (41)(41)(39)
Balance as of June 30, 2021 $ 166,257,900 $17 $20,128 $(31,839)$(95)$(11,789)$(611)$(12,400)

The accompanying notes are an integral part of these unaudited consolidated financial statements.
6

Table of Contents
HYZON MOTORS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (UNAUDITED)CASH FLOWS
(in thousands, except per share amounts)thousands)
Three Months Ended September 30,
Nine Months Ended
September 30,
2021
For the period
January 21, 2020
(Inception) –
September 30,
2020
20212020
(As Restated)(As Restated)
Revenue$89 $ $89 $ 
Operating expense:
Cost of revenue204 — 204 — 
Research and development3,982 104 8,081 163 
Selling, general and administrative42,661 436 51,607 670 
Total operating expenses46,847 540 59,892 833 
Loss from operations(46,758)(540)(59,803)(833)
Other income (expense):
Change in fair value of private placement warrant liability7,614 — 7,614 — 
Change in fair value of earnout liability73,359 — 73,359 — 
Foreign currency exchange loss and other expense(116)(1)(175)(1)
Interest expense, net(254)(15)(5,249)(20)
Total other income (expense)80,603 (16)75,549 (21)
Net income (loss)$33,845 $(556)$15,746 $(854)
Net loss attributable to noncontrolling interest(776)— (1,307)— 
Net income (loss) attributable to Hyzon$34,621 $(556)$17,053 $(854)
Comprehensive income (loss):
Net income (loss)$33,845 $(556)$15,746 $(854)
Foreign currency translation adjustment(187)— (273)— 
Comprehensive income (loss)$33,658 $(556)$15,473 $(854)
Comprehensive loss attributable to noncontrolling interest(749)— (1,269)— 
Comprehensive income (loss) attributable to Hyzon$34,407 $(556)$16,742 $(854)
Net income (loss) per share attributable to Hyzon:
Basic$0.15 $— $0.09 $(0.01)
Diluted$0.14 $— $0.08 $(0.01)
Weighted average common shares outstanding:
Basic234,091 148,405 189,101 148,405 
Diluted246,480 148,405 200,984 148,405 
(unaudited)
Six Months Ended
June 30,
20222021
Cash Flows from Operating Activities:
Net income (loss)$29,973 $(18,099)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization1,606 369 
Stock-based compensation3,052 877 
Deferred income tax expense526 — 
Noncash interest expense— 4,901 
Fair value adjustment of private placement warrant liability(9,938)— 
Fair value adjustment of earnout liability(69,337)— 
(Gain) loss on equity securities(10,082)— 
Equity method investment loss30 — 
Changes in operating assets and liabilities:
Accounts receivable2,920 (1,150)
Inventory(19,009)(1,053)
Prepaid expenses and other current assets1,794 (8,723)
Other assets(430)(164)
Accounts payable(214)839 
Accrued liabilities4,424 2,486 
Related party payables, net(118)(899)
Contract liabilities(3,762)1,237 
Other liabilities(315)(105)
Net cash used in operating activities(68,880)(19,484)
Cash Flows from Investing Activities:
Purchases of property and equipment(7,652)(6,685)
Advanced payments for capital expenditures— (2,224)
Investment in equity securities— (123)
Net cash used in investing activities(7,652)(9,032)
Cash Flows from Financing Activities:
Exercise of stock options40 190 
Payment of finance lease liability(181)(76)
Debt issuance costs— (133)
Proceeds from issuance of convertible notes— 45,000 
Net share settlement of equity awards
(463)— 
Payment under Horizon IP agreement(3,146)— 
Repurchase of warrants(31)— 
Deferred transaction costs— (514)
Net cash (used in) provided by financing activities(3,781)44,467 
Effect of exchange rate changes on cash(140)(66)
Net change in cash, cash equivalents, and restricted cash(80,453)15,885 
Cash, cash equivalents, and restricted cash — Beginning449,365 17,139 
Cash, cash equivalents, and restricted cash — Ending$368,912 $33,024 
Supplemental schedule of non-cash investing activities and financing activities:
Horizon license agreement payable— 10,000 
Transaction costs included in accrued expenses— 2,758 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
7

Table of Contents
HYZON MOTORS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)
(in thousands, except share data)
Legacy Common
Stock
Common Stock
Class A
Additional
Paid-in
Capital
Retained
Earnings
(Accumulated
Deficit)
Accumulated
Other
Comprehensive
Loss
Total Hyzon
Motors Inc.
stockholders’
Equity (Deficit)
Noncontrolling
Interest
Total
Stockholders’
Equity (Deficit)
SharesAmountSharesAmount
Balance as of December 31, 202093,750,000 $94  $ $29,045 $(14,271)$(16)$14,852 $(91)$14,761 
Retroactive application of recapitalization(93,750,000)(94)166,125,000 $17 77 — — — — — 
Adjusted balance, beginning of period  166,125,000 17 29,122 (14,271)(16)14,852 (91)14,761 
Exercise of stock options— — 132,900 — 190 — — 190 — 190 
Stock-based compensation— — — — 816 — — 816 — 816 
IP transaction – deemed distribution— — — — (10,000)— — (10,000)— (10,000)
Net loss attributable to Hyzon— — — — — (17,568)— (17,568)— (17,568)
Net loss attributable to noncontrolling interest— — — — — — — — (531)(531)
Foreign currency translation loss— — — — — — (79)(79)11 (68)
Balance as of June 30, 2021  166,257,900 17 20,128 (31,839)(95)(11,789)(611)(12,400)
Reverse recapitalization transaction, net (Note 4)— — 73,502,303 351,498 — — 351,505 — 351,505 
Issuance of common stock— — 7,234,006 (1)— — — — — 
Vesting of RSUs— — 284,796 — — — — — — — 
Exercise of stock options— — 221,500 — 250 — — 250 — 250 
Stock-based compensation— — — — 28,146 — — 28,146 — 28,146 
Net income (loss) attributable to Hyzon— — — — — 34,621 — 34,621 — 34,621 
Net loss attributable to noncontrolling interest— — — — — — — — (776)(776)
Foreign currency translation loss— — — — — — (232)(232)27 (205)
Balance as of September 30, 2021 (As Restated) $ 247,500,505 $25 $400,021 $2,782 $(327)$402,501 $(1,360)$401,141 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
8

Table of Contents
HYZON MOTORS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)
(in thousands, except share data)
Legacy
Common Stock
Common Stock
Class A
Additional
Paid-in
Capital
Accumulated
Deficit
Accumulated
Other
Comprehensive
Loss
Total Hyzon
Motors Inc.
stockholders’
Equity (Deficit)
Noncontrolling
Interest
Total
Stockholders’
Equity (Deficit)
SharesAmountSharesAmount
Balance as of January 21, 2020 (Inception)83,750,000 $84  $ $ $ $ $84 $ $84 
Retroactive application of recapitalization(83,750,000)(84)148,405,000 $15 69 — — — — — 
Adjusted balance, beginning of period $ 148,405,000 $15 69   84  $84 
Net loss attributable to Hyzon— — — — — (296)— (296)— (296)
Balance as of June 30, 2020 $ 148,405,000 $15 69 (296) (212) $(212)
Net loss attributable to Hyzon— — — — — (556)— (556)— (556)
Balance as of September 30, 2020 $ 148,405,000 $15 $69 $(852)$ $(768)$ $(768)
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
9

Table of Contents
HYZON MOTORS INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(in thousands)
Nine Months Ended
September 30, 2021
For the period
January 21, 2020
(Inception) -
September 30, 2020
(As Restated)
Cash Flows from Operating Activities:
Net income (loss)$15,746 $(854)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization671 99 
Stock-based compensation29,023 — 
Loss on extinguishment of convertible notes107 — 
Noncash interest expense5,449 — 
Fair value adjustment of private placement warrant liability(7,614)— 
Fair value adjustment of earnout liability(73,359)— 
Changes in operating assets and liabilities:
Accounts receivable(5,712)— 
Inventory(12,008)— 
Prepaid expenses and other current assets(19,638)— 
Other assets(150)(14)
Accounts payable3,371 — 
Accrued professional fees and other current liabilities3,082 17 
Operating lease liabilities(187)— 
Related party payables3,821 756 
Contract liabilities4,845 — 
Other liabilities311 — 
Net cash (used in) provided by operating activities(52,242)
Cash Flows from Investing Activities:
Purchases of property and equipment(8,810)(133)
Advanced payments for capital expenditures(3,999)— 
Investment in equity securities(4,826)— 
Net cash used in investing activities(17,635)(133)
Cash Flows from Financing Activities:
Proceeds from issuance of common stock— 84 
Proceeds from Business Combination, net of redemption and transaction costs (Note 4)508,993 — 
Exercise of stock options440 — 
Payment of finance lease liability(135)(12)
Debt issuance costs(133)— 
Proceeds from issuance of convertible notes45,000 500 
Net cash provided by financing activities554,165 572 
Effect of exchange rate changes on cash(853)
Net change in cash and restricted cash483,435 444 
Cash—Beginning17,139 — 
Cash and restricted cash —Ending$500,574 $444 
Supplemental schedule of non-cash investing activities and financing activities:
Lease assets obtained in exchange for lease obligations:
Operating leases6,803 — 
Finance leases— 886 
Conversion of Legacy Hyzon common stock73 — 
Recognition of earnout liability in Business Combination188,373 — 
Recognition of private placement warrant liability in Business Combination19,395 — 
Horizon license agreement payable10,000 — 
Conversion of convertible notes for common stock50,198 — 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
10

Table of Contents
HYZON MOTORS INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Note 1. Nature of Business and Basis of Presentation

Description of Business

Hyzon Motors Inc. (“Hyzon” or the “Company”), formerly known as DCRB, headquartered in Honeoye Falls, New York, was incorporatedis commercializing its proprietary heavy-duty fuel cell technology through manufacturing and retrofitting heavy-duty hydrogen fuel cell electric vehicles (“FCEVs”) in the State of Delaware on January 21, 2020.United States, Europe, and Australia. In addition, Hyzon builds and fosters a clean hydrogen supply ecosystem with leading partners from feedstocks through production, dispensing, and financing. The Company is majority-owned by Hymas Pte. Ltd. (“Hymas”), a Singapore company, which is majority-owned but indirectly controlled by Horizon Fuel Cell Technologies PTE Ltd., a Singapore company (“Horizon”). Hyzon focuses on accelerating decarbonization starting with mobility through the manufacturing and supply of hydrogen fuel cell-powered commercial vehicles across the North American, European, and Australasian regions. In addition, Hyzon focuses on building and fostering a clean hydrogen supply ecosystem with leading partners from feedstocks through production, dispensing and financing.

On February 8, 2021, Legacy Hyzon Motors Inc., now Hyzon Motors USA Inc. (“Legacy Hyzon”), entered into a Business Combination Agreement and Plan of Reorganization (the “Business Combination”) with DCRB to effect a business combination between DCRB and Legacy Hyzon with DCRB Merger Sub Inc., a wholly owned subsidiary of DCRB, merging with and into Legacy Hyzon, with Legacy Hyzon surviving the merger as a wholly owned subsidiary of DCRB. The transaction was unanimously approved by DCRB’s Board of Directors and was approved at a special meeting of DCRB’s stockholders on July 15, 2021. On July 16, 2021, Legacy Hyzon completed its business combination with DCRB. Concurrent with the completion of the business combination, DCRB changed its name to “Hyzon Motors Inc.” and Legacy Hyzon changed its name to “Hyzon Motors USA Inc.”.

Basis of Presentation

The accompanying unaudited interim condensed consolidated financial statements and related disclosures have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) pursuant to the requirements and rules of the SEC forregarding interim reporting. Certain notes or other information that are normally required by U.S. GAAP have been omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited condensedinterim consolidated financial statements should be read in connection with the Company’s audited consolidated financial statements and related notes as of andincluded in the Company’s amended Annual Report filed on Form 10-K/A for the year ended December 31, 2020, included in the Definitive Proxy Statement (the “Proxy”) of DCRB filed with the SEC on June 21, 2021.

Principles of Consolidation

The Company’s condensedunaudited interim consolidated financial statements include the accounts and operations of the Company and its wholly owned subsidiaries including a variable interest entity ofarrangements in which the Company is the primary beneficiary. All intercompany accounts and transactions are eliminated in consolidation.

Unaudited Interim Financial Information

In the opinion of management, in addition to the adjustments to record the Business Combination, the accompanying unaudited condensedinterim consolidated financial statements include all normal and recurring adjustments necessary for a fair presentation for the periods presented. Results of operations reported for interim periods presented are not necessarily indicative of results for the entire year or any other periods.

Variable Interest Entities (VIE)On July 16, 2021 (the “Closing Date”), legacy Hyzon Motors Inc. and now named Hyzon Motors USA Inc., (“Legacy Hyzon”), consummated the transactions contemplated by the Business Combination Agreement and Plan of Reorganization (the “Business Combination”), dated February 8, 2021, with Decarbonization Plus Acquisition Corporation (“DCRB”) to effect a business combination between DCRB and Legacy Hyzon with DCRB Merger Sub Inc., a wholly owned subsidiary of DCRB, merging with and into Legacy Hyzon, with Legacy Hyzon surviving the merger as a wholly owned subsidiary of DCRB. On the Closing Date, DCRB changed its name to “Hyzon Motors Inc.” and Legacy Hyzon changed its name to “Hyzon Motors USA Inc.”

On October 30, 2020, Hyzon entered intoThe Business Combination was accounted for as a joint venture agreement (the “JV Agreement”) with Holthausen Clean Technology Investment B.V. (“Holthausen”) (together referred to as the “Shareholders”) to establish a venture in the Netherlands called Hyzon Europe. The Shareholders combined their resourcesreverse recapitalization in accordance with U.S. GAAP, with no goodwill or other intangible assets recorded and the JV Agreement to mass commercialize fuel cell trucks within the European Union and nearby markets suchnet assets of Legacy Hyzon consolidated with DCRB at historical cost. Under this method of accounting, DCRB is treated as the United Kingdom, the Nordic countries, and Switzerland through Hyzon Europe. Hyzon and Holthausen have 50.5% and 49.5% ownership interest in the equity of Hyzon Europe, respectively.“acquired” company for financial reporting purposes.

Accordingly, the equity structure has been retrospectively adjusted in all comparative periods up to the Closing Date, to reflect the number of shares of the Company's common stock, $0.0001 par value per share issued to Legacy Hyzon's stockholders in connection with the reverse recapitalization. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Hyzon common stock prior to the Business Combination have been retroactively restated as shares reflecting an exchange ratio of 1.772 (the “Exchange Ratio”).

Liquidity

The Company generated net income of $38.8 million and $30.0 million for the three and six months ended June 30, 2022, respectively. The Company incurred net losses of $9.7 million and $18.1 million for the three and six months ended June 30, 2021, respectively. Retained earnings amounted to $9.1 million and accumulated deficit amounted to $26.4 million as of June 30, 2022 and December 31, 2021, respectively. Net cash used in operating activities was $68.9 million and $19.5 million for the six months ended June 30, 2022 and 2021, respectively.
11
8

Table of Contents
The Company has determined that it is the primary beneficiary of Hyzon Europe. As a result, the Company’s Condensed Consolidated Balance Sheets include assets of $29.6 million and $1.0 million as of September 30, 2021, and December 31, 2020, respectively, and liabilities of $14.0 million and $1.2 million as of September 30, 2021, and December 31, 2020, respectively, related to Hyzon Europe.

Segment Information

The Company’s chief operating decision maker (“CODM”), who makes operating decisions, reviews financial information presented on a consolidated basis for the purposes of allocating resources and evaluating financial performance. Accordingly, management has determined that the Company operates as one operating and reportable segment.

Liquidity

As of September 30, 2021, the Company has approximately $498.0 million in unrestricted cash. Cash flows used in operating activities was $52.2 million for the nine months ended September 30, 2021. On July 16, 2021, the Company received $509.0 million in cash, net of redemption and transaction costs as a result of the Business Combination (see Note 4. Business Combination). ManagementCombination. As of June 30, 2022, the Company has $363.9 million in unrestricted cash and cash equivalents and $5.0 million in restricted cash. Restricted cash is pledged as security for letters of credit or other collateral amounts established by the Company for certain lease obligations, corporate credit cards, and other contractual arrangements. The Company’s restricted cash is included within Other assets in the unaudited interim Consolidated Balance Sheets.

As an early stage growth company, the Company expects to continue to incur net losses in the near term. As the Company commenced its internal restructuring effort in 2022, the primary focuses are the advancement of its proprietary fuel cell technology and development and commercialization of single heavy duty commercial vehicle platform in each region by leveraging third party contracted manufacturers. Until the Company can generate sufficient revenue from product sales, retrofit services or lease arrangements to cover operating expenses, working capital and capital expenditures, the Company will need to raise additional capital. The Company expects to fund cash needs through a combination of equity and debt financing, including lease securitization, strategic collaborations, and licensing arrangements. If the Company cannot raise additional funds when needed, our financial condition, business, prospects, and results of operations could be materially adversely affected.

These financial statements have been prepared by management in accordance with U.S. GAAP and this basis assumes that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. These financial statements do not include any adjustments that may result from the outcome of this uncertainty. As of the date of this Quarterly Report on Form 10-Q, management believes that the Company’s cashexisting financial resources will be sufficient to meetexecute its liquidity requirementsoperating priorities for at least one year fromthe next 12 months following the issuance date of these condensed consolidatedunaudited interim financial statements. As of March 31, 2023, unrestricted cash, cash equivalents, and short-term investments were approximately $210 million.

Risks and Uncertainties

The Company is subject to a variety of risks and uncertainties common to early-stage companies that have not yet commenced principal operations including,with a history of losses and are expected to incur significant expenses and continuing losses for the foreseeable future. The risks and uncertainties include, but not limited to, further development of its technology, marketing and distribution channels, further development of its supply chain and manufacturing, development by competitors of new technological innovations, dependence on key personnel, protection of proprietary technology, and the ability to secure additional capital to fund operations.

12

Table of Contents
Reclassifications

Note 2. Restatement of Previously Issued Financial Statements

Management, in concurrence with the Company’s Audit Committee, concluded that the Company's previously issued financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 and the Company's previously issued unaudited interim financial information included in the Company’s Quarterly Reports on Form 10-Q for the periods ended September 30, 2021 and March 31, 2022 (collectively the “Affected Financials Statements”) should no longer be relied upon. Details of the restated condensed consolidated financial statements as of and for the periods ended September 30, 2021 are provided below (“Restatement Items”). The Company evaluated the materiality of these errors both qualitatively and quantitatively in accordance with Staff Accounting Bulletin (“SAB”) No. 99, Materiality andSAB No. 108, Considering the Effects of Prior Year Misstatements in Current Year Financial Statements, and determined the effect of the corrections was material to the Affected Financial Statements. As a result of the material misstatements, the Company has restated its Affected Financial Statements, in accordance with ASC 250, Accounting Changes and Error Corrections.

The Restatement Items primarily reflect adjustments to correct errors related to the recognition of revenue and associated balances for European FCEV transactions, and adjustments to correct errors related to the transaction costs incurred in connection with the Business Combination. In addition to the correction of the errors discussed above, the Company has corrected for Other Immaterial Errors in all Affected Financial Statements.

The Company has also updated all accompanying footnotes and disclosures affected by the Restatement Items and Other Immaterial Errors, respectively, within Note 1. Nature of Business and Basis of Presentation, Note 3. Summary of Significant Accounting Policies, Note 4. Business Combination, Note 5. Revenue, Note 6. Prepaid Expenses and Other Current Assets, Note 10. Income Taxes, Note 11. Fair Value Measurements, Note 13. Stock-based Compensation Plans, Note 15. Related Party Transactions, and Note 16. Earnings (Loss) per Share.

Restatement Items

A.Hyzon Europe revenue transactions - In July 2022, management discovered and brought to the attention of the Board that certain vehicles in China may not have met the criteria necessary to recognize revenue as of December 31, 2021. The Special Committee was formed to conduct an investigation regarding the Company’s revenue recognition timing and internal controls and procedures for both China and Europe operations. The Investigation revealed that for five vehicles for which Hyzon Europe recognized revenue in 2021, Hyzon Europe subsequently performed various levels of work and repair efforts on such vehicles after revenue had been recognized. Consequently, the Company conducted an internal accounting review for its European customer arrangements. The Company determined that the accounting analysis previously applied to certain Hyzon Europe customer contracts, which were assumed from Holthausen Clean Technology B.V. in July 2021, was incorrect. More specifically, the Company previously determined that Hyzon Europe had acquired title to work-in-process vehicles from Holthausen Clean Technology B.V. and had been manufacturing and assembling these FCEVs for subsequent sale to customers. Hyzon Europe had instead assumed service contracts related to the retrofit services to convert the customers' own ICE powered vehicles to hydrogen FCEVs. Therefore, the Company revised its revenue recognition analysis and concluded that Hyzon Europe should not have recorded the assumption of these contracts as inventory and associated contract liabilities, and also should have recognized revenue related to these service contract arrangements on an over-time basis utilizing an input method rather than recording revenue at a point in time. Correction of the error decreased Revenue by $0.9 million, Cost of revenue by $0.8 million, Research and development expense by $0.8 million, increased Selling, general and administrative expense by $0.1 million, Prepaid expenses and other current assets by $0.1 million, decreased Inventory by $2.6 million and Contract liabilities by $3.1 million.

B.Transaction costs - The Company has adjusted its prior allocation of transaction costs incurred in connection with the Business Combination to reflect the allocation of the correct balance of Company incurred transaction costs between the liability classified earnout arrangement and the newly issued equity instruments in the Business Combination in the third quarter of 2021. The adjustment resulted in a reduction of amounts previously allocated to the earnout liability and recognized as expense, offset by an equal increase of transaction costs allocated to the newly issued equity instruments and recorded against additional paid-in capital. Correction of the error decreased Selling, general, and administrative expense and Additional paid-in capital by $3.1 million.

13

Table of Contents
Other Immaterial Errors

In addition to the Restatement Items, the Company has corrected Other Immaterial Errors. While these Other Immaterial Errors are quantitatively and qualitatively immaterial, individually and in the aggregate, because the Company is correcting for the material errors, the Company has decided to correct these Other Immaterial Errors as well. Additionally, certainCertain items previously reported in specific financial statement captions have been reclassified to conform to the current presentation in the condensed consolidated financial statements and the accompanying notes.

These Other Immaterial Errors include adjustments related to the following:

Hyzon Europe lease modification - In connection with the preparation of the Company’s financial results for the year ended December 31, 2021, management identified that one of the Company’s European facility leases was modified in August 2021 and not reflected in the September 30, 2021 balance sheet. The recording of the impact of the lease modification resulted in an increase of Right-of-use assets by $5.6 million, Current portion of lease liabilities by $0.4 million, and Lease liabilities by $5.2 million.

Miscellaneous immaterial errors - Correction of miscellaneous immaterial errors increased Selling, general, and administrative by $0.9 million, decreased Change in fair value of earnout liability by $0.3 million, and increased Earnout liability by $0.3 million and Additional paid-in capital by $0.9 million.

14

Table of Contents

Summary Impact of Restatement Items and Other Immaterial Errors

The following tables present the effect of the Restatement Items, as well as Other Immaterial Errors, on the Company’s condensed consolidated balance sheet for the period indicated (in thousands, except share and per share amounts):
As of September 30, 2021
ASSETSAs Previously ReportedRestatement AdjustmentsRestatement ReferencesAs Restated
Current assets
Cash$498,014 $— $498,014 
Accounts receivable5,991 — 5,991 
Inventory15,260 (2,569)(A)12,691 
Prepaid expenses and other current assets24,555 140 (A)24,695 
Total current assets543,820 (2,429)541,391 
Property, plant, and equipment, net8,878 — 8,878 
Right-of-use assets2,365 5,597 7,962 
Restricted cash and other assets7,755 — 7,755 
Total Assets$562,818 $3,168 $565,986 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable$2,851 — $2,851 
Accrued professional fees1,003 — 1,003 
Other accrued expenses3,154 51 3,205 
Related party payables4,554 — 4,554 
Horizon IP agreement payable10,000 — 10,000 
Contract liabilities10,984 (3,138)(A)7,846 
Current portion of lease liabilities748 416 1,164 
Total current liabilities33,294 (2,671)30,623 
Long term liabilities
Lease liabilities1,930 5,181 7,111 
Private placement warrant liability11,781 — 11,781 
Earnout liability114,758 256 115,014 
Other liabilities316 — 316 
Total liabilities$162,079 $2,766 $164,845 
Commitments and contingencies
Stockholders’ Equity
Common stock, $0.0001 par value; 400,000,000 shares authorized, 247,500,505 and 166,125,000 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively.25 — 25 
Additional paid-in capital402,211 (2,190)(B)400,021 
Retained earnings (accumulated deficit)515 2,267 2,782 
Accumulated other comprehensive loss(326)(1)(327)
Total Hyzon Motors Inc. stockholders’ equity402,425 76 402,501 
Noncontrolling interest(1,686)326 (1,360)
Total Stockholders’ Equity400,739 402 401,141 
Total Liabilities and Stockholders’ Equity$562,818 $3,168 $565,986 



15

Table of Contents

The following tables present the effect of the Restatement Items, as well as Other Immaterial Errors, on the Company’s condensed consolidated statements of operations and comprehensive income (loss) for the periods indicated (in thousands, except per share amounts):
Three Months Ended
September 30, 2021
Nine Months Ended
September 30, 2021
As Previously ReportedRestatement AdjustmentsRestatement ReferencesAs RestatedAs Previously ReportedRestatement AdjustmentsRestatement ReferencesAs Restated
Revenue$962 $(873)(A)$89 $962 $(873)(A)$89 
Operating expense:
Cost of revenue968 (764)(A)204 968 (764)(A)204 
Research and development4,822 (840)(A)3,982 8,921 (840)(A)8,081 
Selling, general and administrative44,784 (2,123)(A) , (B)42,661 53,730 (2,123)(A) , (B)51,607 
Total operating expenses50,574 (3,727)46,847 63,619 (3,727)59,892 
Loss from operations(49,612)2,854 (46,758)(62,657)2,854 (59,803)
Other income (expense):
Change in fair value of private placement warrant liability7,614 — 7,614 7,614 — 7,614 
Change in fair value of earnout liability73,615 (256)73,359 73,615 (256)73,359 
Foreign currency exchange loss and other expense(110)(6)(116)(169)(6)(175)
Interest expense, net(254)— (254)(5,249)— (5,249)
Total other income (expense)80,865 (262)80,603 75,811 (262)75,549 
Net income$31,253 $2,592 $33,845 $13,154 $2,592 $15,746 
Net loss attributable to noncontrolling interest(1,101)325 (776)(1,632)325 (1,307)
Net income attributable to Hyzon$32,354 $2,267 $34,621 $14,786 $2,267 $17,053 
Comprehensive income:
Net income$31,253 $2,592 $33,845 $13,154 $2,592 $15,746 
Foreign currency translation adjustment(205)18 (187)(293)20 (273)
Comprehensive income$31,048 $2,610 $33,658 $12,861 $2,612 $15,473 
Comprehensive loss attributable to noncontrolling interest(1,075)326 (749)(1,594)325 (1,269)
Comprehensive income attributable to Hyzon$32,123 $2,284 $34,407 $14,455 $2,287 $16,742 
Net income per share attributable to Hyzon:
Basic$0.14 $0.01 $0.15 $0.08 $0.01 $0.09 
Diluted$0.13 $0.01 $0.14 $0.07 $0.01 $0.08 
Weighted average common shares outstanding:
Basic234,464 234,091 189,226 189,101 
Diluted246,263 246,480 200,968 200,984 


16

Table of Contents

The following table presents the effect of the Restatement Items, as well as Other Immaterial Errors, on the Company’s condensed consolidated statement of changes in stockholders' equity (in thousands, except share data):

Common Stock Class ARetained Earnings (Accumulated Deficit)Accumulative Other Comprehensive IncomeTotal Hyzon Motors Inc. Stockholders' Equity (Deficit)Noncontrolling InterestTotal Stockholders' Equity
Shares AmountAdditional Paid-in Capital
Balance as of September 30, 2021 (As Previously Reported)247,500,505 $25 $402,211 $515 $(326)$402,425 $(1,686)$400,739 
Cumulative adjustments— — (2,190)2,267 (1)76 326 402 
Balance as of September 30, 2021 (As Restated)247,500,505 $25 $400,021 $2,782 $(327)$402,501 $(1,360)$401,141 


17

Table of Contents
The following tables present the effect of the Restatement Items, as well as Other Immaterial Errors, on the Company’s condensed consolidated statement of cash flows (in thousands):
Nine Months Ended
September 30, 2021
As Previously ReportedRestatement Adjustments***As Restated
Cash Flows from Operating Activities:
Net income$13,154 $2,592 $15,746 
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization671 — 671 
Stock-based compensation28,084 939 29,023 
Loss on extinguishment of convertible notes107 — 107 
Noncash interest expense5,449 — 5,449 
Fair value adjustment of private placement warrant liability(7,614)— (7,614)
Fair value adjustment of earnout liability(73,615)256 (73,359)
Changes in operating assets and liabilities:
Accounts Receivable(5,712)— (5,712)
Inventory(14,577)2,569 (12,008)
Prepaid expenses and other current assets(19,549)(89)(19,638)
Other assets(150)— (150)
Accounts payable2,558 813 3,371 
Accrued professional fees and other current liabilities3,031 51 3,082 
Operating lease liabilities(187)— (187)
Related party payables3,821 — 3,821 
Contract liabilities7,982 (3,137)4,845 
Other liabilities311 — 311 
Net cash used in operating activities(56,236)3,994 (52,242)
Cash Flows from Investing Activities:
Purchases of property and equipment(8,810)— (8,810)
Advanced payments for capital expenditures(3,948)(51)(3,999)
Investment in equity securities(4,826)— (4,826)
Net cash used in investing activities(17,584)(51)(17,635)
Cash Flows from Financing Activities:
Proceeds from issuance of common stock— — — 
Proceeds from Business Combination, net of redemption and transaction costs512,936 (3,943)508,993 
Exercise of stock options440 — 440 
Payment of finance lease liability(135)— (135)
Debt issuance costs(133)— (133)
Proceeds from issuance of convertible notes45,000 — 45,000 
Net cash provided by financing activities558,108 (3,943)554,165 
Effect of exchange rate changes on cash(853)— (853)
Net change in cash and restricted cash483,435 — 483,435 
Cash—Beginning17,139 — 17,139 
Cash and restricted cash —Ending$500,574 $ $500,574 
Supplemental schedule of non-cash investing activities and financing activities:
Lease assets obtained in exchange for lease obligations:
Operating leases1,206 5,597 6,803 
Finance leases— — — 
Conversion of Legacy Hyzon common stock73 — 73 
Recognition of earnout liability in Business Combination188,373 — 188,373 
Recognition of private placement warrant liability in Business Combination19,395 — 19,395 
Horizon license agreement payable10,000 — 10,000 
Conversion of convertible notes for common stock50,198 — 50,198 

*** The adjustments within the condensed consolidated statement of cash flows for the nine months ended September 30, 2021 were due to the reconciliation of the changes in account balances used in preparing the statement of cash flows resulting from the various error corrections included in the above financial statements.
18

Table of Contents
Note 3.2. Summary of Significant Accounting Policies

The Company’s significant accounting policies are described in Note 2.3. Summary of Significant Accounting Policies, toin the Company’s consolidated annual financial statements included in the Company’s amended Annual Report filed on Form 10-K/A for the year ended December 31, 2020, included in2021.

Except for the Proxy. Therepolicy noted below, there have been no material changes to the significant accounting policies during the three-month and nine-month periods ended September 30, 2021, except for the new or updated policies noted.six months ended June 30, 2022.

Revenue
Cash Equivalents
The Company accounts for revenue in accordanceCompany’s cash equivalents consist of short-term, highly liquid financial instruments that are readily convertible to cash with ASC 606. Revenue is based on the amountoriginal maturities of transaction price to which the Company is entitled, subject to the allocation of the transaction price to distinct performance obligations. The Company recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration for which the Company expects to receive in exchange for those goods or services. To determine revenue recognition, the Company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation.

When it determines it is not probable that it will collect all of the consideration to which it will be entitled under a customer contract, the Company concludes the contract existence criteria under ASC 606 are not met. In these cases, the Company recognizes revenue to the extent of consideration received provided the amounts are non-refundable, the Company has transferred control of the goods or services to which the consideration relates, the Company has stopped transferring goods or services, and there is no obligation to transfer additional services ("Alternative Method for Revenue Recognition").

The Company recognizes the incremental costs of obtaining contracts, including commissions, as an expense when incurred as the contractual period of the Company's arrangements are expected to be one yearthree months or less. Amounts billedDue to customers related to shipping and handling are classified as revenue, andtheir short-term nature, the Company has elected to recognize theamortized cost for freight and shipping when control over vehicles, parts, or accessories has transferred to the customer as an expense in Cost of revenue.

Product Sales

The Company enters into sales contracts with customers for the purchase of the Company’s products and services including fuel cell systems, FCEVs, parts, product support, and other related services.cash equivalents approximate fair value. As of June 30, 2022, the Company’s cash equivalents consisted of money market funds totaling $100.0 million. The Company considers order confirmations or purchase orders, which in some cases are governed by master vehicle supply agreements, to be contracts with a customer. The Company recognizes revenue when it satisfies a performance obligation by transferring controldid not have any cash equivalents as of product(s) or service to a customer. On standard vehicle sales contracts, revenues are recognized at a point in time when customers obtain control of the vehicle, which among other indicators, is generally when transfer of title and risks and rewards of ownership of goods have passed and when the Company has a present right to payment. Provisions for warranties are made at the time of sale. Sales, value-added, and other taxes collected concurrent with revenue producing activities are excluded from revenue.

Payment terms for sales of FCEVs to certain customers have included installment billing terms to fund the Company’s working capital requirements. The Company does not adjust the transaction price for a significant financing component when the performance obligation is expected to be fulfilled within a year as the amount is not material.

In China, the Company has granted extended payment terms to customers, which resulted in the Company concluding collection of all of the consideration under the contract is not probable. As a result, the contract existence criteria is not met and revenue is recognized under the Alternative Method of Revenue Recognition, which may not be in the same period that control of the related goods is transferred to the customers (see Note 5. Revenue). The Company does not include a right of return on its products other than rights related to standard warranty provisions that permit repair or replacement of defective goods.December 31, 2021.

199

Table of Contents
Retrofit ServicesNote 3. Revenue

The Company also enters intorecognized negligible revenue and $2.9 million in sales of hydrogen fuel cell systems in the United States, sales of FCEVs in China, and retrofit services in Europe for the three and six months ended June 30, 2022, respectively. The Company did not recognize any revenue for the three and six months ended June 30, 2021.

In accordance with ASC 606, the Company is required to evaluate customers’ ability and intent to pay substantially all of the consideration to which the Company is entitled in exchange for the vehicles transferred to the customer, i.e., collectability of contracts with customerscustomers. The customer in China, to retrofit ICE vehicleswhich the Company delivered 62 FCEVs in 2021, is a special purpose entity established in response to FCEVs. In general,China’s national hydrogen fuel cell vehicle pilot program. While in the Company’s estimation the customer controls any workhas strong business plans and management teams, in process arising fromconsideration of the Company’s performance;customer’s limited operating history and extended payment terms in their contracts, the Company determined the collectability criterion is not met with respect to contract existence under ASC 606, and therefore, an alternative method of revenue recognition has been applied to the arrangement. The $2.5 million of revenue recognized under this arrangement in the six months ended June 30, 2022 is equal to the remaining consideration received after satisfying local government VAT obligations, as such amounts are non-refundable and the Company has in effect agreedtransferred control of the 62 FCEVs to sell its rightswhich the consideration relates and has stopped transferring goods or services to the work as it performs on a continuous basis. Revenue from these contracts is generally recognized over time utilizing an input method. Under the input method, the extent of progress towards completion is measured based on the ratio of normal costs incurred to date to the total estimated costs at completion of the performance obligation. Unexpected amounts of wasted materials, labor or other resources are excluded from the cost-to-cost measure of progress.customer. The Company believes that this method iswill continue to monitor the most accurate representationcustomer and evaluate the collectability criterion as of the Company's performance, because it directly measures the valueeach reporting period. The total cost of the services transferredFCEVs delivered to the customer over time as the Company incurs costs on its contracts. Contract costs include all direct materials, labor, and indirect costs related to contract performance, which may include indirect labor, supplies, tools, repairs and depreciation costs. The amount of revenue recognized for these contracts in a period is dependent on our ability to estimate total contract costs. The Company continually evaluates its estimates of total contract costs based on available information and experience.

Warranties

In most cases, products that customers purchase from the Company are covered by one to six-year limited product warranty. At the time revenue is recognized, the Company estimates the cost of expected future warranty claims and accrues estimated future warranty costs. These estimates are based on industry information, actual claims incurred to date and an estimate of the nature, frequency and costs of future claims. These estimates are inherently uncertain given the Company’s relatively short history, and changes to the historical or projected warranty experience may cause changes to the warranty reserve when the Company accumulates more actual data and experience in the future. The Company will periodically review the adequacy of its product warranties and adjust, if necessary, the warranty percentage and accrued warranty liability for actual historical experience. Accrued warranty obligations are recorded within Other liabilities and warranty expenses areChina was recorded within Cost of revenue.

Restricted Cash

Restricted cash consists of funds that are contractually restricted as to usage or withdrawal. The Company presents restricted cash separately from unrestricted cash on the Condensed Consolidated Balance Sheets. As of September 30, 2021, the Company has $2.6 million in restricted cash included within Restricted cash and other assets, the balance is primarily comprised of $2.4 million in certain letters of credit. The Company had no restricted cash as of December 31, 2020.

Inventories

Inventories are stated at the lower of cost and net realizable value. Cost is determined using the first-in, first-out method (“FIFO”) for all inventories. As of September 30, 2021, the Company had inventory comprised of raw materials and work in process of $11.5 million and $1.2 million, respectively. The Company had no inventory as of December 31, 2020.

Warrant Liabilities

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidancerevenue in the Financial Accounting Standards Board (“FASB”) ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance and adjusted to the current fair value at each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (see Note 14. Warrants).
20

Tablein 2021 since control of Contents

Earnout liability

As a result of the Business Combination, the Company recognized earnout shares to Legacy Hyzon’s common stockholders as a liability. Pursuant to ASC 805-10, Business Combinations (“ASC 805”) the Company determined that the initial fair value of the earnout shares should be recorded as a liability with the offset going to Additional paid-in capital and with subsequent changes in fair value recorded in the statement of operations at each reporting period. The earnout shares to other holders of outstanding equity awards are accounted for under ASC 718, Stock Compensation (“ASC 718”), as these earnout shares are compensatory in nature and relate to services provided or to be providedsuch FCEVs was transferred to the Company.

Note 4. Business Combination

As discussed in Note 1. on July 16, 2021, Legacy Hyzon consummated the transaction contemplated by the Business Combination. Immediately upon the completion of the Business Combination and the other transactions contemplated by the Business Combination, Legacy Hyzon became a direct, wholly owned subsidiary of DCRB. In connection with these transactions, DCRB changed its name to “Hyzon Motors Inc.”

The Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP, with no goodwill or other intangible assets recorded and the net assets of Legacy Hyzon consolidated with DCRB at historical cost. Under this method of accounting, DCRB is treated as the “acquired” company for financial reporting purposes. The reverse recapitalization is retrospectively adjusted in the consolidated statements of changes in stockholders’ equity to reflect the Company’s equity structure for all periods presented.

As a result of the Business Combination, each share of common stock of Legacy Hyzon, par value $0.001 per share, was converted to 1.772 shares of Class A common stock (the “Exchange Ratio”), par value $0.0001 per share of the Company, resulting in the issuance of approximately 173.4 million shares of Class A common stock. Additionally, the Company reserved for issuance approximately 21.7 million shares of Class A common stock in respect to outstanding options and restricted stock units (“RSUs”) issued in exchange for options, RSUs and warrants of the Company.

Immediatelycustomer prior to the Business Combination, Legacy Hyzon issued to Hymas approximately 4.1 million shares of Legacy Hyzon common stock without any consideration, which was converted to approximately 7.2 million of Class A common stock.

DCRB held subscription agreements with certain investors to issue and sell an aggregate of 35,500,000 shares of Class A common stock of DCRB for $10.00 per share for an aggregate commitment of $355,000,000 (the “PIPE Financing”). At the closing of the Business Combination, DCRB consummated the PIPE Financing, and those proceeds became part of the Company’s capital.

Pursuant to the terms of the Convertible Notes described in Note 8, immediately prior to the Business Combination the outstanding principal of $45 million as well as the accrued interest on the Convertible Notes automatically converted into shares of the Company at a price per share equal to 90% of the price per share paid by the PIPE Financing investors, and upon the closing, converted into 5,022,052 shares of common stock of the post-combination company.

In accordance with an agreement executed in July 2020, Ascent Funds Management LLC (“Ascent”) was granted options to purchase shares of Legacy Hyzon common stock (the “Ascent Options”) at an exercise price of $2.73 per share. Immediately prior to the consummation of the Business Combination, the Ascent Options were automatically exercised in full on a cashless basis into approximately 3.9 million shares of Legacy Hyzon common stock, which converted into approximately 6.9 million shares of Class A common stock in connection with the Business Combination.

Immediately after giving effect to the Business Combination, PIPE Financing, Convertible Note conversion, and Ascent Options exercise described above, there were 246,994,209 shares of Class A common stock of the Company issued and outstanding.
21

Table of Contents
The number of shares of common stock issued immediately following the consummation of the Business Combination:
Shares
Common stock of DCRB20,483,179 
DCRB founders5,643,125 
Total DCRB26,126,304
Conversion of Ascent Options (post-cashless exercise)6,871,667 
Conversion of convertible notes5,022,052 
PIPE shares35,500,000 
Reverse capitalization transaction73,520,023
Legacy Hyzon shares after conversion (1)
173,474,186
Total shares of Common Stock immediately after Business Combination246,994,209
(1)The number of Legacy Hyzon shares was determined from the 97,897,396 shares of Legacy Hyzon common stock outstanding immediately prior to the closing of the Business Combination converted at the Exchange Ratio of 1.772. All fractional shares were rounded down.

The following table reconciles the elements of the Business Combination to the Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2021 (in thousands):

Recapitalization
Cash – DCRB trust and cash, net of redemptions and liabilities recorded by DCRB of $24.9 million$179,727 
Cash – PIPE Financing, net of transaction costs of $14.2 million340,797 
Less: transaction costs allocated to equity(11,531)
Effect of Business Combination, net of redemption and transaction costs$508,993

The Company issued equity classified common shares and certain liability classified earnout shares. Transaction costs of $3.3 million attributable to the liability classified earnout shares were expensed. The rest was attributable to the equity classified common shares and recorded as a reduction to Additional paid-in capital in the Condensed Consolidated Balance Sheets.

The following table reconciles the elements of the Business Combination to the Condensed Consolidated Statements of Changes in Stockholders’ Equity for the nine months ended September 30, 2021 (in thousands):
Recapitalization
Cash – DCRB trust and cash, net of redemptions and liabilities recorded by DCRB of $24.9 million$179,727 
Cash – PIPE Financing, net of transaction costs of $14.2 million340,797 
Conversion of convertible notes into common stock50,198 
Recognize earnout liability(188,373)
Recognize Private Placement Warrants liability(19,395)
Recapitalization of Legacy Hyzon common shares75 
Less: transaction costs allocated to equity(11,531)
Effect of Business Combination, net of redemption and transaction costs$351,498
22

Table of Contents

Warrants

On October 22, 2020, DCRB consummated the Initial Public Offering of 22,572,502 units and each unit consists of one share of Class A common stock and one-half of one public warrants (the “Public Warrants”). Simultaneously with the closing of the Initial Public Offering, DCRB consummated the private sale of 6,514,500 warrants (the “Private Placement Warrants”), including 514,500 warrants as a result of the underwriters’ partial exercise of their over-allotment option on November 12, 2020, at a price of $1.00 per Private Placement Warrant in a private placement to Decarbonization Plus Acquisition Sponsor, LLC (the “Sponsor”), DCRB’s independent directors and an affiliate of DCRB’s chief executive officer. At the closing of the Business Combination, DCRB and the Sponsor entered into a note agreement, whereby the Sponsor agreed to loan DCRB an aggregate of $1,500,000 to cover working capital requirements. The note agreement converted at the Business Combination date into 1,500,000 additional Private Placement Warrants. Upon the closing of the Business Combination, Hyzon assumed these outstanding warrants. See Note 16. Shareholders’ Equity.

Earnout

Following the closing of the Business Combination, holders of the Company’s legacy common stock and outstanding equity awards (including warrant, stock option and RSU holders) were granted the right to receive up to an aggregate amount of 23,250,000 shares of Class A common stock that would vest in in three tranches of (i) 9,000,000, (ii) 9,000,000 and (iii) 5,250,000 shares if the trading price of the common stock of the Company achieves $18, $20, and $35, respectively, as its last reported sales price per share for any 20 trading days within any 30 consecutive trading day period within five years following the closing date of the Business Combination, provided that in no event will the issuance of the 5,250,000 earnout shares occur prior to the one-year anniversary of the closing date. Upon forfeiture of underlying unvested equity awards prior to occurrence of targeted trading price noted above, the associated earnout shares shall be allocated pro-rata among the remaining eligible Company’s common stock and equity awards holders.

The Company recognized earnout shares to Legacy Hyzon’s common stockholders as a liability. The earnout liability was $115.0 million and $188.4 million as of September 30, 2021 and at the close of the Business Combination, respectively. The change in earnout liability was recorded as other income in Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). The Company recognized the earnout shares to other equity holders as separate and incremental awards from other equity holders’ underlying stock-based compensation awards in accordance with ASC 718.

Certain earnout awards accounted for under ASC 718 were vested at the time of grant, and therefore recognized immediately as compensation expense. Certain other earnout awards accounted for under ASC 718 contained performance and market-based vesting conditions, and as the performance conditions are not deemed probable at September 30, 2021, no compensation expense has been recorded related to these awards. Total compensation expense recorded in the three and nine months ended September 30, 2021 related to earnout awards was $14.0 million.

Note 5. RevenueDecember 31, 2021.

Contract LiabilitiesBalances

Contract liabilities relate to the advance consideration invoiced or received from customers for products and services prior to satisfying a performance obligation or in excess of amounts allocated to a previously satisfied performance obligation. These amounts are included

The current portion of contract liabilities is recorded within Contract liabilities in the accompanying Condensed Consolidated Balance Sheets.

The carrying amount of Contract liabilities included in the accompanying Condensed Consolidated Balance Sheets was $7.8and totaled $2.1 million and $2.6$10.9 million as of SeptemberJune 30, 2021,2022 and December 31, 2020,2021, respectively. The long-term portion of contract liabilities is recorded within Other liabilities in the Consolidated Balance Sheets and totaled $6.0 million and $1.0 million as of June 30, 2022 and December 31, 2021, respectively. As part of efforts to exit certain customer contracts, the Company refunded $1.3 million to customers in the third and fourth quarters of 2022.

Remaining Performance Obligations

The transaction price associated with remaining performance obligationsobligations for commercial vehicles and other contracts with customers was $14.6$15.4 million as of SeptemberJune 30, 2021, of which the Company2022. The Company expects to recognize approximately 5% of its remaining performance obligations as revenue over the next 12 months.twelve months after June 30, 2022.

Note 4. Inventory     

Inventory consisted of the following (in thousands):
June 30,
2022
December 31,
2021
Raw materials$26,196 $16,099 
Work in process13,938 4,828 
Total inventory$40,134 $20,927 

2310

Table of Contents

Note 6.5. Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):
September 30, 2021December 31, 2020
Deposit for fuel cell components (Note 15)$5,000 $— 
Vehicle inventory deposits5,996 577 
Production equipment deposits3,948 — 
Other prepaid expenses1,050 271 
Prepaid Insurance7,505 — 
VAT receivable from government1,196 — 
Total prepaid expenses and other current assets24,695 848 

June 30,
2022
December 31,
2021
Deposit for fuel cell components (Note 14)$9,420 $5,008 
Vehicle inventory deposits9,010 10,171 
Production equipment deposits582 1,169 
Other prepaid expenses3,024 3,266 
Prepaid insurance865 5,079 
VAT receivable from government1,589 2,159 
Total prepaid expenses and other current assets$24,490 $26,852 

Note 7.6. Property, Plant, and Equipment, net

Property, plant, and equipment, net consisted of the following (in thousands):

September 30, 2021December 31, 2020June 30,
2022
December 31,
2021
Land and buildingLand and building$2,424 $— Land and building$2,818 $2,818 
Machinery and equipmentMachinery and equipment5,728 371 Machinery and equipment12,731 8,827 
SoftwareSoftware168 — Software1,687 507 
Leasehold improvementsLeasehold improvements358 — Leasehold improvements1,225 746 
Construction in progressConstruction in progress663 60 Construction in progress4,640 2,139 
Total Property, plant, and equipmentTotal Property, plant, and equipment9,341 431 Total Property, plant, and equipment23,101 15,037 
Less: Accumulated depreciation and amortizationLess: Accumulated depreciation and amortization(463)(13)Less: Accumulated depreciation and amortization(1,861)(691)
Property, plant and equipment, netProperty, plant and equipment, net$8,878 $418 Property, plant and equipment, net$21,240 $14,346 

Depreciation and amortization expense totaled $0.2$0.7 million and $0.5$1.3 million for the three months and ninesix months ended SeptemberJune 30, 2021.2022, respectively. Depreciation and amortization expense was negligibletotaled $0.2 million for the three and six months ended SeptemberJune 30, 2020, and the period from inception (January 21, 2020) to September 30, 2020.
2021, respectively.

Note 8. Convertible Notes7. Accrued liabilities

In February 2021, the Company entered into a Convertible Notes Purchase Agreement with certain investors for the purchase and sale of $45 million in Convertible Notes (the “Convertible Notes”). The Convertible Notes accrued interest at an annual rate of 1% commencing upon issuance and compounding semi-annually on each August 1 and February 1. Interest was payable by increasing the principal amountAccrued liabilities consisted of the Convertible Notes (with such increased amount accruing interest as well) on each interest payment due date.following (in thousands):

As the Convertible Notes contained various settlement outcomes, the Company evaluated each scenario for accounting purposes. The conversion features settled at discounts upon certain financing events were determined to be redemption features and were evaluated as embedded derivatives and bifurcated from the Convertible Notes due to the substantial premium to be paid upon redemption. At issuance, option-based features were determined to have a de minimis fair value, and non-option-based features were bifurcated assuming the issuance fair value was zero. Changes in the derivative liability fair values were reported in operating results each reporting period, prior to the close of the Business Combination.

The period from July 1, 2021 to the close date of the Business Combination the Company recorded de minimis amount of interest expense related to the stated interest for the Convertible Notes and $0.3 million related to the change in the value of the bifurcated embedded derivative within interest expense.
June 30,
2022
December 31,
2021
Payroll and payroll related expenses$3,324 $2,250 
Accrued professional fees2,398 2,450 
Accrued product warranty cost826 816 
Accrued contract manufacturer costs1,446 — 
Other accrued expenses2,924 1,254 
Accrued liabilities$10,918 $6,770 

2411

Table of Contents
The period from February 2021 to the close date of the Business Combination the Company recorded $0.2 million of interest expense related to the stated interest for the Convertible Notes and $5.0 million related to the change in the value of the bifurcated embedded derivative within interest expense.

Upon the closing, the Convertible Notes and the accrued interest automatically converted into 5,022,052 shares of common stock of the Company (see Note 4. Business Combination).

Note 9.8. Investments in Equity Securities

The Company has certain equity security investments which are included in Restricted cash and other assets on the Condensed Consolidated Balance Sheets.

The Company owns common shares, participation rights, and options to purchase additional common shares in certain private companies. On a non-recurring basis, the carrying value is adjusted for changes resulting from observable price changes in orderly transactions for identical or similar investments in the same issuer or an impairment.

Included in Gain (loss) on equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the six months ended June 30, 2022 is a $12.5 million gain related to the equity investment in Raven SR, Inc. (“Raven”). The investment in Raven’s common shares and options were initially accounted for at cost of $2.5 million. In March 2022, there was an observable change in price of Raven’s common shares. The change in observable price of Raven’s common shares also results in a remeasurement of the investment in Raven’s options as of the date that the observable transaction took place. The fair value of the investment in Raven’s common shares was determined based on observable market prices of identical instruments in less active markets and is classified accordingly as Level 2 in the fair value hierarchy. Due to certain anti-dilution rights included in the options held by the Company, the fair value was determined utilizing a Monte-Carlo simulation model. Accordingly, this was determined to be a Level 3 measurement in the fair value hierarchy. The most significant assumptions in the model included the transaction price of the underlying common shares at the transaction date, expected volatility, risk free rate, and certain assumptions around the likelihood, size, and timing of potential future equity raises by Raven. As of March 31, 2022, the period end in which the observable change in price occurred, the Company determined the fair value of the investment in Raven’s common shares and options to be $6.5 million and $8.5 million, respectively.

Additionally, included in Gain (loss) on equity securities in the unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) for the three and six months ended June 30, 2022 is a $2.4 million impairment loss related to the Company’s investment in Global NRG H2 Limited (“NRG”). The Company, a New Zealand corporation, equal to the initial cost basis. In accordance with ASC 321, Investments - Equity Securities (“ASC 321”), the investment in NRG does not have controla readily determinable fair value and does not have the ability to exercise significant influence over the operating and financial policies of this entity. The Company’s investment totaled $0.1 million as of December 31, 2020 and increased to $2.5 million as of September 30, 2021.

On July 29, 2021,is measured at cost minus impairment, which requires the Company entered into a Master Hub Agreement with Raven SR, LLC (“Raven SR”) whereby Raven SR granted to evaluate on an ongoing basis whether an investment has been impaired based on qualitative factors. The Company impaired NRG due to the Company a rightinvestee’s lack of first refusal to co-investprogress in up to 100 of Raven SR’s first 200 solid waste-to-hydrogen generationdeveloping its plans and production facilities hubs), and up to 150 of Raven SR’s gas-to-hydrogen generation and production facilities across the United States on a hub-by-hub basis. In connection with this agreement, Hyzon invested $2.5 million on July 30, 2021, to acquire a minority interest in Raven SR.operating performance.

The Company’sfollowing table summarizes the total investments in equitycarrying value of held securities, measured as of September 30, 2021, and December 31, 2020, were $5.0 million and $0.1 million, respectively.the total initial cost plus cumulative net gain (loss) (in thousands):

June 30,
2022
December 31,
2021
Total initial cost basis$4,948 $4,948 
Adjustments:
Cumulative unrealized gain12,530 — 
Cumulative impairment(2,448)— 
Carrying amount, end of period$15,030 $4,948 

The following table summarizes unrealized gain and impairment recorded in Other income (expense) in the unaudited Consolidated Statements of Operations and Comprehensive Income (Loss), which are included as adjustments to the carrying value of equity securities (in thousands):

Three Months Ended
June 30,
Six Months Ended
June 30,
 2022 2021 2022 2021
Unrealized gain on equity securities$— $— $12,530 $— 
Cumulative impairment(2,448)— (2,448)— 
Total unrealized gain and impairment on equity securities$(2,448)$ $10,082 $ 

12

Table of Contents
Note 10.9. Income Taxes

For the six months ended June 30, 2022, the Company recorded a net discrete tax expense of $0.5 million primarily associated with the establishment of a deferred tax liability that is not expected to offset available deferred tax assets. The Company did not record a provision for income taxes for the three or nine months ended SeptemberJune 30, 2022, because the Company generated tax losses. The Company did not record a provision for income taxes for the three and six months ended June 30, 2021 because it expects to generate a loss for the year ending December 31, 2021, and the Company’s net deferredCompany generated tax assets continue to be fully offset by a valuation allowance.losses.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company assesses all available evidence, both positive and negative, to determine the amount of any required valuation allowance within each taxing jurisdiction. Full valuation allowances have been established for the Company’s operations in all jurisdictions. As of SeptemberJune 30, 2021,2022, and December 31, 2020,2021, the Company had net deferred tax assets of approximately $12.2$31.8 million and $3.1$23.0 million, respectively, each of which was fully offset by a valuation allowance. During the three months ended September 30, 2021, and September 30, 2020, the Company did not record an income tax benefit (expense) as a result of the full valuation allowances recorded against its deferred tax assets. During the nine months ended September 30, 2021, and the period from inception (January 21, 2020) to September 30, 2020, the Company did not record an income tax benefit (expense) as a result of the full valuation allowances recorded against its deferred tax assets.

There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of SeptemberJune 30, 2021,2022 and December 31, 2020.2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its positions. The Company is subject to income tax examinations by major taxing authorities in the countries in which it operates since inception.

Note 11.10. Fair Value Measurements

The Company follows the guidance in ASC 820, Fair Value Measurement. For assets and liabilities measured at fair value on a recurring and nonrecurring basis, a three-level hierarchy of measurements based upon observable and unobservable inputs is used to arrive at fair value. The Company uses valuation approaches that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.

25

Table of Contents
Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability.

Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date.

As of SeptemberJune 30, 2021,2022, and December 31, 2020,2021, the carrying amount of accounts receivable, prepaid expenses and other current assets, restricted cash and other assets, accounts payable, and accrued professional fees and other accrued expenses approximated theirliabilities approximate estimated fair value due to their relatively short maturities.

The Company did not have warrant liabilities or earnout liabilities as of December 31, 2020. The following table presentstables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value (in thousands):

Fair Value Measurements on a Recurring BasisAs of June 30, 2022
Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:Assets:
Cash equivalentsCash equivalents$100,000 $— $— $100,000 
Liabilities:Liabilities:
Warrant liability – Private Placement WarrantsWarrant liability – Private Placement Warrants$— $— $11,781 $11,781 Warrant liability – Private Placement Warrants$— $5,290 $— $5,290 
Earnout shares liabilityEarnout shares liability— — 115,014 115,014 Earnout shares liability— — 34,424 34,424 

Private Placement Warrants

The estimated fair value of the private placement warrants (the “Private Placement Warrants”) is determined using Level 3 inputs by using the binominal lattice model (“BLM”). The application of BLM requires the use of several inputs and significant unobservable assumptions, including volatility. Significant judgment is required in determining the expected volatility of the Company’s common stock. The following table provides quantitative information regarding Level 3 fair value measurement inputs:
September 30, 2021July 16, 2021
Stock price$6.94 $10.33 
Exercise price (strike price)$11.50 $11.50 
Risk-free interest rate0.9 %0.8 %
Volatility60.00 %34.20 %
Remaining term (in years)4.795.00

The following table presents the changes in the liability for Private Placement Warrants during the nine months ended September 30, 2021 (in thousands):

Balance as of July 16, 2021$19,395 
Change in estimated fair value(7,614)
Balance as of September 30, 2021$11,781 
2613

Table of Contents
As of December 31, 2021
Level 1Level 2Level 3Total
Liabilities:
Warrant liability – Private Placement Warrants$— $15,228 $— $15,228 
Earnout shares liability— — 103,761 103,761 

Cash Equivalents

The Company’s cash equivalents consist of short-term, highly liquid financial instruments that are readily convertible to cash with original maturities of three months or less. As of June 30, 2022, the Company has $100.0 million invested in money market funds.

Earnout to Common Stockholders

The fair value of the earnout shares was estimated by utilizing a Monte-Carlo simulation model. The inputs into the Monte-Carlo pricing model included significant unobservable inputs. The following table provides quantitative information regarding Level 3 fair value measurement inputs:
September 30, 2021July 16, 2021June 30,
2022
December 31,
2021
Stock priceStock price$6.94 $10.33 Stock price$2.94 $6.49 
Risk-free interest rateRisk-free interest rate0.9 %0.8 %Risk-free interest rate3.0 %1.2 %
VolatilityVolatility90.00 %90.00 %Volatility95.0 %90.0 %
Remaining term (in years)Remaining term (in years)4.795.00Remaining term (in years)4.044.54

The following table presents the changes in earnout liability during the nineliabilities for Private Placement Warrants and Earnout for the six months ended SeptemberJune 30, 20212022 (in thousands):
Balance as of July 16, 2021
Private Placement WarrantsEarnout
Balance as of December 31, 2021$15,228 $103,761 
Change in estimated fair value(9,938)(69,337)
Balance as of June 30, 2022$5,290 $34,424 

$188,373 
Change in estimated fair value(73,359)
Balance as of September 30, 2021$115,014 
The Company performs routine procedures such as comparing prices obtained from independent sources to ensure that appropriate fair values are recorded.

14

Table of Contents
Note 12.11. Commitments and Contingencies

Legal Proceedings

From timeThe Company is subject to, time, the Companyand may become involved in legal proceedings or be subjecta party to, a variety of litigation, other claims, suits, indemnity demands, regulatory actions, and government investigations and inquiries in the ordinary course of business. WhileThe assessment as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves significant judgment about future events, and the outcome of litigation is inherently uncertain. The Company accrues for matters when we believe that losses are probable and can be reasonably estimated. As the outcome of individual matters is not predictable with assurance, the assessments are based on the Company’s knowledge and information available at the time; thus, the ultimate outcome of any matter could require payment substantially in excess of the amount being accrued and/or disclosed. The Company is a party to current legal proceedings as discussed more fully below, the Company does not believe that these proceedings, if determined adversely to the Company, would individually or in the aggregate have a material adverse effect on the Company’s business, financial condition, or results of operations. Regardless of outcome, such proceedings or claims can have an adverse impact on the Company because of legal defense and settlement costs, diversion of resources and other factors, and there can be no assurances that favorable outcomes will be obtained.
Prior to the completion of the Business Combination, certain purported DCRB stockholders filed lawsuits against DCRB and its directors asserting claims for breaches of fiduciary duty (Lanctot v. Decarbonization Plus Acquisition Corp. et al., Index No. 652070/2021 (N.Y. Sup. Ct., N.Y. County); Pham v. Decarbonization Plus Acquisition Corp. et al., No.21-CIV-01928 (Cal. Sup., San Mateo County)). These complaints allege that the DCRB board members breached their fiduciary duties in connection with the merger by allegedly agreeing to the transaction following an inadequate process and at an unfair price, and by allegedly disseminating inaccurate or incomplete information concerning the transaction. These complaints seek, among other things, injunctive relief, damages, and an award of attorneys’ fees. The defendants in these cases have not yet answered these complaints and the Company believes that these lawsuits are without merit.below.

On September 28, 2021, Blue Orca Capital released a report indicating that it held a short position in the Company’s stockShareholder Securities and making numerous allegations about the Company. On October 5, 2021, the Company issued a press release denying the allegations and correcting numerous false claims and assertions in the report. TwoDerivative Litigation

Three related putative securities class action lawsuits were filed against the Company, certain of its current officers and directors and certain officers and directors of DCRB between September 30, 2021 and October 13,November 15, 2021, in the U.S. District Court for the Western District of New York (Kauffmannagainst the Company, certain of the Company’s current and former officers and directors and certain former officers and directors of DCRB (Kauffmann v. Hyzon Motors Inc.Inc., et al. (No.6:21-cv-06612-CJS); (No. 21- cv-06612-CJS), Brennan v. Hyzon Motors Inc.Inc., et al. (No.6:(No. 21-cv-06636-CJS), and Miller v. Hyzon Motors Inc. et al. (No. 21-cv-06695-CJS)), asserting violations of federal securities laws under Sections 10(b) and 20(a) of the Exchange Act, and Rule 10b-5 thereunder.laws. The complaints generally allege that the Company and individual defendants made materially false and misleading statements relating to the nature of itsthe Company’s customer contracts, vehicle orders, and sales and earnings projections, based on allegations in thea report released on September 28, 2021, by Blue Orca Capital, report.an investment firm that indicated that it held a short position in the Company’s stock and which has made numerous allegations about the Company. These lawsuits have been consolidated under the caption In re Hyzon Motors Inc. Securities Litigation (Case No. 6:21-cv-06612-CJS-MWP), and on March 21, 2022, the court-appointed lead plaintiff filed a consolidated amended complaint seeking monetary damages. The Company intendsand individual defendants moved to vigorously defenddismiss the consolidated amended complaint on May 20, 2022, and the court-appointed lead plaintiff filed its opposition to the motion on July 19, 2022. The court-appointed lead plaintiff filed an amended complaint on March 21, 2022, and a second amended complaint on September 16, 2022. Briefing regarding the Company and individual defendants’ anticipated motion to dismiss the second amended complaint has been stayed pending a scheduled, non-binding mediation among the parties. There is no assurance that the mediation will proceed as scheduled, or that, if mediation occurs, any or all parties will reach a settlement.

Between December 16, 2021, and January 14, 2022, three related shareholder derivative lawsuits were filed in the U.S. District Court for the Western District of New York (Lee v. Anderson et al. (No. 21-cv-06744-CJS), Révész v. Anderson et al. (No. 22-cv-06012-CJS), and Shorab v. Anderson et al. (No. 22-cv-06023-CJS)). These three lawsuits have been consolidated under the caption In re Hyzon Motors Inc. Derivative Litigation (Case No. 6:21-cv-06744-CJS). On February 2, 2022, a similar shareholder derivative lawsuit was filed in the U.S. District Court for the District of Delaware (Yellets v. Gu et al. (No. 22-cv-00156)). On February 3, 2022, a similar shareholder derivative lawsuit was filed in the Supreme Court of the State of New York, Kings County (Ruddiman v. Anderson et al. (No. 503402/2022)). On February 13, 2023, a similar shareholder derivative lawsuit was filed in the Delaware Court of Chancery (Kelley v. Knight et al. (C.A. No. 2023-0173)). These lawsuits name as defendants the Company’s current and former directors and certain former directors of DCRB, along with the Company as a nominal defendant, and generally allege that the individual defendants breached their fiduciary duties by making or failing to prevent the misrepresentations alleged in the consolidated securities class action, and assert claims for violations of federal securities laws, breach of fiduciary duties, unjust enrichment, abuse of control, gross mismanagement, and/or waste of corporate assets. These lawsuits generally seek equitable relief and monetary damages. With the exception of the recently filed action in the Delaware Court of Chancery, each of the shareholder derivative actions has been stayed or the parties have jointly requested that it be stayed pending a decision regarding the anticipated motion to dismiss in the consolidated securities class action.

On March 18, 2022, a putative class action complaint, Malork v. Anderson et al. (C.A. No. 2022-0260- KSJM), was filed in the Delaware Court of Chancery against these claims.certain officers and directors of DCRB, DCRB’s sponsor, and certain investors in DCRB’s sponsor, alleging that the director defendants and controlling shareholders of DCRB’s sponsor breached their fiduciary duties in connection with the merger between DCRB and Legacy Hyzon. The complaint seeks equitable relief and monetary damages. On May 26, 2022, the defendants in this case moved to dismiss the complaint. On August 2, 2022, the plaintiff filed an amended complaint. Defendants filed a motion to dismiss the amended complaint on August 15, 2022.

2715

Table of Contents
Between January 26, 2022 and August 22, 2022, Hyzon received demands for books and records pursuant to Section 220 of the Delaware General Corporation Law from four stockholders who state they are investigating whether to file similar derivative or stockholder lawsuits, among other purposes. On May 31, 2022, one of these four stockholders represented that he had concluded his investigation and did not intend to file a complaint. On November 18, 2022, a second of the four stockholders filed a lawsuit in the Delaware Court of Chancery (Abu Ghazaleh v. Decarbonization Plus Acquisition Sponsor, LLC et al. (C.A. No. 2022-1050)), which was voluntarily dismissed shortly thereafter on December 1, 2022. On February 13, 2023, a third of these four shareholders filed a derivative lawsuit in the Delaware Court of Chancery (Kelley v. Knight et al. (C.A. No. 2023-0173)). The complaint asserts claims for breach of fiduciary duty and generally alleges that the individual defendants breached their fiduciary duties by making or failing to prevent misrepresentations including those alleged in the consolidated securities class action and the report released by Blue Orca Capital. As with the previously filed shareholder derivative lawsuits, the complaint seeks equitable relief and monetary damages.

On April 18, 2023, the Company received a demand for books and records pursuant to Section 220 of the Delaware General Corporation Law from a stockholder seeking to investigate possible breaches of fiduciary duty or other misconduct or wrongdoing by the Company's controlling stockholder, Hymas Pte. Ltd. ("Hymas"), Hyzon's board of directors (the "Board") and/or certain members of Hyzon's senior management team in connection with the Company's entrance into (i) an equity transfer agreement (the "Equity Transfer") with certain entities affiliated with the Company, and (ii) the share buyback agreement with the Hymas (the "Share Buyback" and, together with the Equity Transfer, the "Transactions") as reported by the Company in its Form 8-K filed on December 28, 2022.

The above proceedings are subject to uncertainties inherent in the litigation process. The Company cannot predict the outcome of these matters or estimate the possible loss or range of possible loss, if any at this time.

Government Investigations

On January 12, 2022, the Company received a subpoena from the SEC for production of documents and information, including documents and information related to the allegations made in the September 28, 2021 report issued by Blue Orca Capital. The Company received two additional subpoenas in connection with the SEC’s investigation on August 5, 2022 and August 10, 2022. On October 31, 2022, the U.S. Attorney’s Office for the Southern District of New York (“SDNY”) notified the Company that it is also investigating these matters. The Company is cooperating and will continue to cooperate with these and any other regulatory or governmental investigations or inquiries. The Company cannot predict the ultimate outcome of the SEC and the SDNY investigations or inquiries. It is not possible to accurately predict at this time when matters will be completed, the final outcome as a result of those investigations or inquiries, what if any actions may be taken by the SEC or the SDNY, or the effect that such actions may have on our business, prospects, operating results and financial condition, which could be material.

Customer and Supplier Dispute

From time to time, the Company is subject to various commercial disputes or claims with its customers or suppliers. In January 2023, Duurzaam Transport B.V. and H2 Transport B.V., both private limited companies in the Netherlands and customers of the Company’s European subsidiary, Hyzon Motors Europe B.V. (“Hyzon Europe”), filed an attachment with the local Dutch court. The initial attachment claimed that Hyzon Europe was liable for liquidated and consequential damages stemming from Hyzon Europe allegedly not delivering trucks as contracted. The initial attachment placed a lien on the assets of Hyzon Europe. Following the attachments, Duurzaam Transport B.V. and H2 Transport B.V. initiated proceedings on the merits in February 2023. Eventually, the dispute was settled without any party admitting liability, and the Company made a payment of €2.1 million (approximately $2.2 million in USD) in April 2023.

Regardless of outcome, such proceedings or claims can have an adverse impact on the Company because of legal defense and settlement costs, the Company’s obligations to indemnify third parties, diversion of resources, and other factors, and there can be no assurances that favorable outcomes will be obtained. Based on the early-stage nature of these cases, the Company cannot predict the outcome of these currently outstanding customer and supplier dispute matters or estimate the possible loss or range of possible loss, if any.

16

Table of Contents
Note 13.12. Stock-based Compensation Plans

2020The following table summarizes the Company’s stock option and Restricted Stock Incentive PlanUnit (“RSU”) activity:
Stock OptionsRSUs
Number of OptionsWeighted Average Exercise PriceWeighted Average Remaining Contractual (Years)Aggregate Intrinsic Value (in 000s)Number of RSUsWeighted Average Grant Date Fair Value
Outstanding at December 31, 202119,311,140 $1.29 13.07100,885 1,852,685 $6.14 
Granted188,232 $6.29 — — 747,162 $4.70 
Exercised or released(35,324)$1.13 — — (263,030)$4.58 
Forfeited/Cancelled(56,704)$1.13 — — (75,605)$4.87 
Outstanding at June 30, 202219,407,344 $1.47 12.5429,337 2,261,212 $5.89 
Vested and expected to vest, June 30, 202213,869,844 $1.15 12.1525,557 2,261,212 $5.89 
Exercisable and vested at June 30, 202212,406,490 $1.13 12.8022,472 — 

In January 2020, Legacy Hyzon adopted the 2020 Stock Incentive Plan (the “2020 Plan”) underAs of June 30, 2022, there was $2.4 million of unrecognized stock-based compensation expense related to unvested stock options, which employees, directors, and consultants mayis expected to be granted various formsrecognized over a weighted-average period of equity incentive compensation including incentive and non-qualified options.4.22 years.

A total number of 16,250,000 shares of common stock were reserved for awardsRSUs granted under the 2020 Plan. Shares of common stock issued under the Plan may be either authorized but unissued sharesCompany’s equity incentive plans typically vest over a four or reacquired common stock of Legacy Hyzon. Under the 2020 Plan, the exercisefive-year period of options is determined when granted, and options expire no later than fifteen years frombeginning on the date of grant, subject to terms and limitations relative to terminationgrant. RSUs will be settled through the issuance of service and ownership percentages of the voting power of all classes of Legacy Hyzon’s stock.
The 2020 Plan was terminated in connection with the Business Combination in July 2021, and Legacy Hyzon will not grant any additional awards under the 2020 Plan. Any ungranted shares under the 2020 plan expired. However, the 2020 Plan will continue to govern the terms and conditions of the outstanding awards previously granted under it. At the closing of the Business Combination, the outstanding awards under the 2020 Plan were converted at an Exchange Ratio of 1.772. Share and per share information below have been converted from historical disclosure based on the Exchange Ratio.

2021 Equity Incentive Plan

The 2021 Equity Incentive Plan (the “2021 Plan”) was approved by the Board of Directors on June 24, 2021, and subsequently approved by the stockholders on July 15, 2021. The 2021 Plan provides for the grant of stock options, stock appreciation rights, restricted stock, RSU and performance awards to the Company’s employees, directors, and consultants. Theequivalent number of shares of the Company’s common stock reserved for issuance underand are equity classified. The fair value of restricted shares is determined based upon the 2021 Plan is 23,226,543 shares. In connection with the Business Combination, 21,339,493 shares of Class A common stock subject to outstanding equity awards granted under the 2020 Plan are converted into equity awards under the 2021 Plan. The number of shares of common stock available for issuance under the 2021 Plan will also include an annual increaseprice on the first daydate of each year beginning ingrant. As of June 30, 2022, and ending in 2031, equalunrecognized compensation costs related to the lesserunvested RSUs of (A) two and one-half percent$11.1 million is expected to be recognized over a remaining weighted average period of the shares outstanding on the last day of the immediately preceding fiscal year and (B) such smaller number of shares as determined by the Board of Directors.
Former CTO Retirement Agreement3.37 years.

In September 2021,Earnout to Other Equity Holders

Earnout awards to other equity holders accounted for under ASC 718, Compensation - Stock Compensation (“ASC 718”) were vested at the Companytime of grant, and former Chief Technology Officer (“former CTO”) entered into a Letter Agreement (the “Agreement”) concerningtherefore recognized immediately as compensation expense. Total compensation expense recorded for the former CTO’s retirementthree and separation from Hyzon. Pursuant to the Agreement, for a period of 24six months commencing on September 18, 2021 (the “Initial Consulting Period”), he will serve as a consultant to Hyzon. In exchange for services provided during the Initial Consulting Period, he will receive $20,000 per month. Subject to conditions of the Letter Agreement, the 1,772,000 stock options previously granted pursuant to his employment agreement with the Company will continue to vest annually in equal installments from April 1,ended June 30, 2022 through April 1, 2025. He also will be entitled to receive 250,000 RSUs of Hyzon, half of which vested after his retirement date and half of which will vest on or after the one-year anniversary of his retirement date. The service condition in the Agreement related to the vesting ofthese earnout awards was $0.8 million and $0.9 million, respectively. No compensation expense related to these awards was determinedrecorded for the three and six months ended June 30, 2021. Certain earnout awards to be non-substantive,other equity holders contained performance and therefore,market-based vesting conditions, and as the Company recognized stock-basedperformance conditions are not deemed probable at June 30, 2022, no compensation expense of $13.4 million immediately in September 2021. In addition, the Company recognized salary expense of $0.5 millionhas been recorded related to his monthly consulting payments.these awards.

Stock-based Compensation Activities
17

During the three months ended September 30, 2021, the Company did not grant any stock options. During the nine months ended September 30, 2021, the Company granted 134,672 stock options with a weighted average grant date fair value of $1.68 per share that vest over five years. During the three months ended September 30, 2021, 221,500 options were exercised resulting in proceeds of $0.3 million, and 107,206 options were forfeited or replaced. During the nine months ended September 30, 2021, 354,409 options were exercised resulting in proceeds of $0.4 million, and 174,542 options were
28

Table of Contents
forfeited or replaced. There was no option activity in the three months ended September 30, 2020, or the period from inception (January 21, 2020) to September 30, 2020.Note 13. Stockholders' Equity

During the three months ended September 30, 2021, the Company granted 864,765 RSUs with a weighted average grant date fair value of $8.04 per share. During the three months ended September 30, 2021, 450,643 RSUs were forfeited. During the nine months ended September 30, 2021, the Company granted 2,622,589 RSUs with a weighted average grant date fair value of $4.44 per share. The RSUs granted during the three months and nine months ended September 30, 2021, vest over periods ranging from four to five years. The Company did not grant RSUs in the three months ended September 30, 2020, or the period from inception (January 21, 2020) to September 30, 2020.

As of September 30, 2021, there were 19,757,800 options with a weighted average exercise price of $1.13, and 2,171,946 RSUs outstanding. There were no stock options or RSUs outstanding as of September 30, 2020.Common Stock

The Company recognized stock-based compensation expense, inclusiveis authorized to issue 400,000,000 shares of all employees, former CTO’s awards,common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. At June 30, 2022 and earnout shares to other equity holders, of $28.1 million and $29.0 million for the three and nine months ended September 30, 2021, respectively. As of September 30, 2021, the total remaining unrecognized compensation expense related to nonvested stock-based compensation awards was $12.6 million, which is expected to be recognized over the remaining vesting period of the respective grants, through the third quarter of 2026.

Note 14. Warrants

As of September 30,December 31, 2021, there were 19,300,742 warrants outstanding,248,006,857 and 247,758,412 shares of which 11,286,242 are public warrants (the “Public Warrants”) and 8,014,500 were Private Placement Warrants. Each whole warrant entitles the registered holder to purchase one share ofClass A common stock at a price of $11.50 per share, subject to adjustment as discussed below. Only whole warrants are exercisable. The warrants will expire on the earlier to occur of: (i) the fifth anniversary of the completion of the Company’s Business Combination, (ii) their redemption or (iii) the liquidation of the Company.

Once the warrants become exercisable, the Company may redeem theissued and outstanding, warrants for cash:respectively.

Warrantsin whole and not in part;

atAt June 30, 2022, there were 11,013,665 Public Warrants and 8,014,500 Private Placement Warrants, for a pricetotal of $0.01 per warrant;
upon19,028,165 warrants outstanding. At December 31, 2021, there were 11,286,242 Public Warrants and 8,014,500 Private Placement Warrants, for a minimumtotal of 19,300,742 warrants outstanding. At June 30, days’ prior written notice of redemption, which the Company refers to as the “30-day redemption period”;2022, and December 31, 2021, there were 200,048 and 275,048 Ardour Warrants outstanding, respectively.

if, and only if, the last reported sale price of the Company’s common stock has been at least $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations, and the like) on each of 20 trading days within the 30-trading day period ending on the third business day prior to the date on which the notice of redemption is given.Equity Repurchase Program

OnceOn November 17, 2021, the warrants become exercisable,Company’s board of directors authorized the repurchase of up to $5.0 million of its outstanding common stock and/or Public Warrants. The timing and amount of any share repurchases under the Company’s share repurchase authorization will be determined by management based on market conditions and other considerations. Such repurchases may be executed in the open market. As of December 31, 2021, the Company may redeem the outstandinghad repurchased 256,977 public warrants for common stock:$0.5 million. In the six months ended June 30, 2022, the Company repurchased an additional 15,600 public warrants for $31 thousand. The Company repurchased a total of 272,577 public warrants and suspended the share repurchase program as of January 5, 2022.

in whole and not in part;
18

at a price of $0.10 per warrant;

upon a minimum of 30 days’ prior written notice of redemption;
if, and only if, the last reported sale price of the Company’s common stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations, and the like) on the trading day prior to the date on which the notice of redemption is given; and

if the last sale price of the Company’s common stock on the trading day prior to the date on which the notice of redemption is given is less than $18.00 per share (as adjusted for stock splits, stock dividends,
29

Table of Contents
reorganizations, recapitalizations, and the like), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants.

The terms of the Private Placement Warrants are identical to the Public Warrants as described above, except that the Private Placement Warrants are not redeemable (except as described above) so long as they are held by the sponsor or its permitted transferees.

The Public Warrants are classified as equity and subsequent remeasurement is not required. The Private Placement Warrants are classified as liabilities and are initially recorded at their fair value, within warrant liability on the Condensed Consolidated Balance Sheets, and remeasured at each subsequent reporting date. Changes in the fair value of these instruments are recognized within Change in fair value of warrant liabilities in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

The fair value of the Private Placement Warrants on July 16, 2021, in the amount of $19.4 million was recorded as a Private placement warrant liability and a reduction to Additional paid-in capital on the Condensed Consolidated Balance Sheets. The change in fair value for the three and nine months ended September 30, 2021, in the amount of $7.6 million was recorded as a reduction in Private placement warrant liability on the Condensed Consolidated Balance Sheets and a gain from change in fair value of private placement warrant liability on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

Note 15.14. Related Party Transactions

Horizon IP Agreement

In January 2021, the Company entered into an intellectual property agreement (the “Horizon IP Agreement”) with Jiangsu Qingneng New Energy Technologies Co., Ltd. and Shanghai Qingneng Horizon New Energy Ltd. (together, “JS Horizon”) both of which are affiliatessubsidiaries of the Company’s ultimate parent, Horizon. Under the Horizon IP Agreement, JS Horizon assigned to the Company a joint ownership interest in certain intellectual property rights previously developed by JS Horizon (“Background IP”), and each of Hyzon and JS Horizon granted to the other, within such other party’s field of use, exclusive licenses under their respective joint ownership rights in the Background IP, as well as their rights in improvements made in the future with respect to such Background IP. Under that agreement, the Company also grants JS Horizon a perpetual non-exclusive license under certain provisional patent applications (and any patents issuing therefrom), as well as improvements thereto. OnIn September 27, 2021, the Horizon IP Agreement was amended to add Jiangsu Horizon Powertrain Technologies Co. Ltd. (“JS Powertrain”) as a party.

The Horizon IP Agreement revised and clarifiedwas an added party to the agreement. Pursuant to the agreement the parties convey to each other certain rights in intellectual property arrangements existing as of the Company’s inception, as set forthrelating to Hyzon’s core fuel cell and mobility product technologies, under two previous agreements. Under a license agreement made effective at the time of the Company’s inception (the “License Agreement”), the Company received an exclusive license under certain of the Background IP. That agreementwhich Hyzon was later terminated and replaced with a Partial Assignment Agreement of Fuel Cell Technology, dated November 19, 2020 (the “Partial Assignment Agreement”), which contemplated a joint ownership structure with respect to certain of the Background IP similar to the structure set forth under the now existing Horizon IP Agreement. Both the original License Agreement and Partial Assignment Agreement have been superseded by the Horizon IP Agreement.

Under the terms of the Horizon IP Agreement, the Company will pay JS Horizon and JS Powertrain $10a total fixed payment of $10.0 million. The full $10.0 million as consideration for the rights it receives under the Background IP and improvements thereto. Subsequent to September 30, 2021,has been paid, $6.9 million was paid in 2021 and the remainder is expected to beremaining $3.1 million was paid in December 2021.

Because the Company is under common control with Horizon and JS Horizon, the cost of the intellectual property transferred should equal the historical cost of the Company’s ultimate parent, Horizon. Due to the creation of the Background IP through research and development over a long period of time, the historical cost of the intellectual property acquired is zero. As such, no asset was recorded for the Background IP on the Company’s balance sheet. The difference between the fixed amounts payable to JS Horizon and JS Powertrain and the historical cost is treated as a deemed distribution to Horizon, given the common control.
30

Table of Contents
February 2022.

Related Party Payables and Receivables

Horizon Fuel Cell Technologies and Related Subsidiaries

Hyzon utilizes Horizon and its subsidiaries to supply certain fuel cell components. In March 2021, theThe Company made a deposit payment to Horizon in the amount of $5.0 million in March 2021, and additional deposit payments totaling $4.4 million in 2022 to secure fuel cell components. This payment iscomponents, which are included within Prepaid expenses and other current assets in prepaid expenses as none of the components have yet been received.unaudited interim Consolidated Balance Sheets.

Certain employees of Horizon and its affiliatessubsidiaries provide research and development, staff training, and administrative services to the Company. Based on an analysis of the compensation costs incurred by Horizon and an estimate of the proportion of effort spent by such employees on each entity, an allocation of approximately $1.2$0.2 million and $0.1 $0.5 million was recorded in the Company’s Condensedunaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) related to such services for the three months ended SeptemberJune 30, 2022, and 2021, and September 30, 2020, respectively. An allocation of approximately $1.8$0.5 million and $0.4 $0.6 million was recorded in the Company’s Condensedunaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) related to such services for the ninesix months ended SeptemberJune 30, 2022, and 2021, and the period from inception (January 21, 2020) to September 30, 2020, respectively.

The related party liabilitypayable to Horizon and affiliatesits subsidiaries is $3.8$0.1 million and $0.6$3.7 million as of SeptemberJune 30, 2021,2022 and December 31, 2020,2021, respectively.

Holthausen and Affiliates

The Company entered into a joint venture agreement in October 2020 to create Hyzon Europe with Holthausen.Holthausen Clean Technology Investments B.V. (“Holthausen”). As Hyzon Europe builds out its production facilities, it relies on Holthausen and its affiliates for certain production resources that result in related party transactions. In addition, both companies rely on certain suppliers, including Horizon.

In JulyThe Company currently owns 50.5% of the equity interests of Hyzon Europe. On December 31, 2021, Hyzon executed a non-binding Letter of Intent (“LOI”) with Holthausen to increase its stake to 75% in Hyzon Europe. Concurrent with the signing of this LOI, a €1 million refundable deposit was paid to Holthausen, approximately $1.1 million in U.S. dollars (“USD”). This deposit is recorded within Prepaid expenses and other current assets in the unaudited interim Consolidated Balance Sheets .

Subsequently, in December 2022, the Company acquired the remaining 49.5% of the equity interests of Hyzon Europe from Holthausen. The Company now holds 100% ownership in Hyzon Europe. The Company paid €3.5 million (approximately $3.7 million in USD), in addition to €1.0 million (approximately $1.1 million in USD) paid in December 2021. As part of this transaction, the Company also transferred various inventory items to, and settled open related party balances with, Holthausen. In addition, the Company reassigned all of the assumed certain retrofit service contracts, fromincluding after-sales obligations, back to Holthausen Clean Technology B.V. The

For the three and six months ended June 30, 2022, the Company incurredpaid $0.1 million and $0.3 million, respectively, to acquire these contracts.Carl Holthausen and Max Holthausen as managing directors of Hyzon Europe. For the three and six months ended June 30, 2021, the Company paid $0.2 million and $0.2 million, respectively.

As of SeptemberJune 30, 2021,2022, the Company has a net related party payable into Holthausen is $0.1 million. As of December 31, 2021, the amountrelated party receivable from Holthausen is $0.3 million.

19

Table of $0.8 million due to Holthausen.Contents
Note 16. Earnings15. Income (Loss) per Shareshare

Basic net income (loss) per share is computed by dividing net income attributable to shareholders of Hyzon by the weighted-average number of common shares outstanding during the reporting period. Diluted net income per share is computed similarly to basic net income per share, except that it includes the potential dilution that could occur if dilutive securities were exercised.

The following table presents the information used in the calculation of the Company’s basic and diluted earningsnet income (loss) per share attributable to Hyzon common stockholders (in thousands, except per share data):
Three Months Ended September 30,Nine Months Ended
September 30,
Inception
(January 21,
2020) to
September 30,
Three Months Ended
June 30,
Six Months Ended
June 30,
20212020202120202022202120222021
Net income (loss) attributable to HyzonNet income (loss) attributable to Hyzon$34,621 $(556)$17,053 $(854)Net income (loss) attributable to Hyzon$41,999 $(9,421)$35,476 $(17,568)
Weighted average shares outstanding:Weighted average shares outstanding:Weighted average shares outstanding:
BasicBasic234,091 148,405 189,101 148,405 Basic248,056 166,249 247,999 166,225 
Effect of dilutive securitiesEffect of dilutive securities12,389 — 11,883 — Effect of dilutive securities10,209 — 10,773 — 
DilutedDiluted246,480 148,405 200,984 148,405 Diluted258,265 166,249 258,772 166,225 
Earnings (loss) per share attributable to Hyzon:
Net income (loss) per share attributable to Hyzon:Net income (loss) per share attributable to Hyzon:
BasicBasic$0.15 $— $0.09 $(0.01)Basic$0.17 $(0.06)$0.14 $(0.11)
DilutedDiluted$0.14 $— $0.08 $(0.01)Diluted$0.16 $(0.06)$0.14 $(0.11)

The weighted average number of shares outstanding prior to Business Combination were converted at anthe Exchange RatioRatio.

Potentially dilutive shares are excluded from the computation of 1.772.diluted net income (loss) per share when their effect was antidilutive. The potential dilutive securities are summarized as follows (in thousands):
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Restricted stock units1,591 1,758 965 1,758 
Stock options with service conditions188 14,570 188 14,570 
Stock options with market and performance conditions5,538 5,538 5,538 5,538 
Private placement warrants8,015 — 8,015 — 
Public warrants11,014 — 11,014 — 
Earnout shares23,250 — 23,250 — 
Hongyun warrants31 — 31 — 

3120

Table of Contents
The following shares were not included in the calculation of the weighted average diluted shares outstanding as the effect would have been anti-dilutive or the shares are contingently issuable, but all necessary conditions have not been satisfied for the periods indicated (in thousands):
Three Months Ended September 30,Nine Months Ended
September 30,
Inception
(January 21,
2020) to
September 30,
2021202020212020
Stock options and restricted stock units426 — 426 — 
Stock options with market and performance conditions5,538 — 5,538 — 
Private placement warrants8,015 — 8,015 — 
Public Warrants11,286 — 11,286 — 
Earnout shares23,250 — 23,250 — 
Ardour warrants326— 326— 

In the three and nine months ended September 30, 2020, the weighted average number of shares outstanding used to calculate both basic and diluted net loss per share attributable to common shares is the same because the Company reported a net loss for each of these periods and the effect of inclusion would be antidilutive. There were no potentially dilutive securities for the three months ended September 30, 2020 or the period from inception (January 21, 2020) to September 30, 2020.

Note 17.16. Subsequent Events

Global NRG H2 LimitedOrten Business Combination Cancellation

During the quarter endedIn June 30, 2022, the Company determined that there wasentered into an agreement with the intention of acquiring 100% of outstanding ownership in Orten Betriebs GmbH and subsidiaries, and Orten Electric Trucks GmbH (collectively “Orten”). Subsequently, in September 2022, the Company terminated the agreement. As a full impairmentresult of the Company’s $2.5termination, the Company transferred consideration of €8.5 million investment(approximately $8.4 million in NRG. For additional information regarding the NRG investment referUSD) to Note 9. InvestmentsOrten consisting of €6.1 million (approximately $6.1 million in Equity Securities to the condensed consolidated financial statements.USD) in cash and €2.4 million (approximately $2.3 million in USD) in vehicle inventory.

Holthausen and AffiliatesRaven SR S1 LLC

In December 2022, the Company acquiredentered into an agreement with Chevron New Energies and Raven, to invest in Raven SR S1 LLC. Raven SR S1 LLC intends to develop, construct, operate and maintain a solid waste-to hydrogen generation production facility located in Richmond, California. The Company invested $8.5 million at closing, and the remaining 49.5% stake, or 1,485,000 A Shares par value €0.01$1.5 million will be paid in 2023 for an approximate 20% ownership in Raven SR S1 LLC. The Company accounted for the agreement as an equity method investment with a cost basis determined by the funding date capital contribution. The subsequent payment will add to the overall cost basis of the investment when paid.

Divestiture of Hyzon Guangdong

In December 2022, the Company sold all of its equity interest in Hyzon EuropeMotors Technology (Guangdong) Co., Ltd. (“Hyzon Guangdong”) to Hymas for approximately $3.1 million in cash, subject to certain adjustments. As a common control transaction, the difference of $0.5 million between the consideration received and the book value is expected to be recognized in the Company’s additional paid-in-capital during the three months ended December 31, 2022. Subsequent to the divestiture, Hyzon Guangdong changed its name to Guangdong Qingyun Technology Co. Ltd. (“Guangdong Qingyun”).

Additionally, together with the execution of the Hyzon Guangdong divestiture, the Company entered into a share buyback agreement and repurchased approximately 3.8 million shares of common stock from Holthausen. The Company now holds 100% ownershipHymas in Hyzon Europe. The considerationexchange for approximately $6.4 million in cash.

In April 2023, Guangdong Qingyun paid by$3.3 million to the Company to Holthausen was €5.52 million (approximately $5.84 million in USD), consisting of €4.50 million (approximately $4.76 million in USD) in cash, including prepaidsettle intercompany balances and €1.02Hymas paid the Company $3.1 million (approximately $1.08 million in USD) (excluding any VAT)related to the Hyzon Guangdong divestiture.

Nasdaq Deficiency Notice

In February 2023, the Company received a Staff Determination from the Listing Qualifications Staff of certain inventory. In addition, Hyzon Europe transferred allNasdaq notifying the Company that unless the Company requests an appeal, trading of the assumed retrofit service contracts including after-sales obligations backCompany's Class A common stock and warrants will be suspended from The Nasdaq Capital Market at the opening of business on February 14, 2023, and a Form 25-NSE will be filed with the SEC. On February 10, 2023, the Hearings Panel granted the Company a 15 calendar day stay of delisting, and will notify the Company within this 15 calendar day period whether the Company’s request for a stay pending the hearing will be granted. The date for the delisting hearing was March 16, 2023. At the hearing, the Company presented its plan to Holthausen Clean Technology B.V. upon closingregain compliance with Nasdaq Listing Rule 5250(c)(1) and requested the continued listing of its securities on The Nasdaq Capital Market pending such compliance. In March 2023, the transaction.Company received a letter from the Hearings Panel indicating that the Hearings Panel granted the Company’s request for continued listing until May 15, 2023, in order to allow the Company to regain compliance with the periodic filing rule.

On April 6, 2023, the Company received an additional Staff Determination (the “Additional Staff Determination”) from the Staff notifying the Company that, because the Staff did not receive the Company’s Form 10-K for the year ended December 31, 2022, the Company does not comply with Nasdaq’s Listing Rules for continued listing, thus constituting an additional basis for delisting the Company’s securities from The Nasdaq Capital Market. The Additional Staff Determination further notified the Company that the Hearings Panel will consider this matter in their decision regarding the Company’s continued listing on The Nasdaq Capital Market, and that the Company should present its views with respect to this additional deficiency to the Hearings Panel in writing no later than April 13, 2023. On April 13, 2023, the Company filed its response to the Additional Staff Determination.

Delaware Court of Chancery Section 205

On February 13, 2023, the Company filed a petition under the caption In re Hyzon Motors Inc., C.A. No. 2023-0177-LWW (Del. Ch) in the Delaware Court of Chancery pursuant to Section 205 of the Delaware General Corporation Law (“DGCL”), which permits the Court of Chancery, in its discretion, to validate potentially defective corporate acts due to developments regarding potential interpretations of the DGCL stemming from the Court’s recent decision in Garfield v. Boxed, Inc., 2022 WL 17959766 (Del. Ch. Dec. 27, 2022). On March 6, 2023, the Court of Chancery granted our petition, holding that any defects that may have existed with respect to the conduct of the Special Meeting of Shareholders held on July 15, 2021 to approve the increase in the Company’s authorized share capital were ratified as of the meeting.

The Company continues to believe that, notwithstanding the relief the Delaware Court of Chancery granted to the Company under Section 205, at the time of DCRB Shareholder Meeting on July 16, 2021, the increase in the Company’s authorized share capital was validly approved by DCRB’s shareholders under Delaware law.

3221

Table of Contents

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

This report contains forward-looking statements within the meaning of the Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, without limitation, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this report, the words “could,” “should”, “will,” “may,” “anticipate,” “believe,” “expect,” “estimate,” “intend,” “plan,” “project,” the negative of such terms and other similar expressions are intended to identify forward looking statements, although not all forward-looking statements contain such identifying words. Such forward-looking statements are based on management’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events.
Except with respect to statements in this Form 10-Q/A revised or provided to reflect the effects of the Restatement, forward-looking statements herein are as of the Original Filing, filed with the SEC on November 15, 2021, unless specifically stated to be made as of a different date, and the Company has not updated forward-looking statements or information to reflect events occurring after the Original Filing.

Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to, those described below and under the sections entitled “Risk Factors “and “Cautionary Note Regarding Forward-Looking Statements” included in the Definitive Proxy Statement (the “Proxy”) of DCRB filed with the SEC on June 21, 2021 and in subsequent reports that we file with the SEC, including this Form 10-Q/A for the quarter ended September 30, 2021.

our ability to commercialize our strategic plans, including our ability to establish facilities to produce our vehicles or secure hydrogen supply in appropriate volumes, at competitive costs or with competitive emissions profiles;

our ability to effectively compete in the heavy-duty transportation sector, and intense competition and competitive pressures from other companies worldwide in the industries in which we operate;

our ability to maintain the listing of our common stock on Nasdaq;
our ability to raise financing in the future;

our ability to retain or recruit, or changes required in, our officers, key employees or directors; and

our ability to protect, defend or enforce intellectual property on which we depend

Should one or more of the risks or uncertainties described above, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements.

The forward-looking statements contained in this report are based on our current expectations and beliefs concerning future developments and their potential effects on us and speak only as of the date of this report. Except as otherwise required by applicable law, we disclaim any duty to update any forward looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this report. You should, however, review additional disclosures we make in subsequent filings with the SEC.

The following discussion and analysis providesprovide information that management believes is relevant to an assessment and understanding of our consolidated results of operations and financial condition. This discussion is intended to supplement, and should be read in conjunction with the accompanying unaudited condensed consolidated financial statements and notes thereto included as a part of the Form 10-Q/A to which this Management’s“Management’s Discussion and Analysis of Financial Condition and Results of Operation is attached.Operations” included in our 2021 Annual Report filed on Form 10-K/A. Unless the context otherwise requires, all references in this section to “Hyzon,” “we,” “us,” and “our” are intended to mean the business and operations of Hyzon Motors Inc. and its consolidated subsidiaries following the consummation of the Business Combination and to Legacy Hyzon and its consolidated subsidiaries prior to the Business Combination.

33

Table of Contents
Restatement

The accompanying Management’s Discussion and Analysis (“MD&A”) of Financial Condition and Results of Operations has been adjusted to give effect to the Restatement of the unaudited condensedconsolidated financial statements for the periods ended September 30, 2021. For additional information and a detailed discussion of the Restatement, refer to the Explanatory Note and Note 2. Restatement of Previously Issued Financial Statements to the condensed consolidated financial statements.

Overview

Headquartered in Rochester,Honeoye Falls, New York, with major operations in North America, Europe,the United States, the Netherlands, and Australasia,Australia. Hyzon is an energy transition accelerator and technology innovator, providing end-to-endprovides decarbonized solutions primarily for the commercial mobility sector. We operate two lines of businesses: commercial vehicles market and hydrogen supply infrastructure.

Vehicles and Vehicle Platforms

Our commercial vehicle business is focused primarily on assembling and supplying battery-electrichydrogen-powered fuel cell electric vehicles (“FCEVs”). Our new strategy takes a focused approach by designing and FCEVs, such as heavy-duty (Class 8)developing one vehicle platform at each region to conform with regional regulations and customer preferences. Our strategy to manufacture fuel cells in-house and work with 3rd party vehicle assemblers will enable us to maintain an asset-light business model, lower production costs and ultimately lower Total Cost of Ownership (“TCO”) for the customer, which is a prerequisite for scaling deployments of heavy and medium duty trucks medium-duty (Class 6) trucks, light-duty (Class 3) trucks, and 40- and 60-foot (12 and 18-meter) city and coach buses to commercial vehicle operators. We also provide services that retrofit ICE vehicles to FCEVs.with customers.

On-road, our potential customers include shipping and logistics companies and retail customers with large distribution networks, such as grocery retailers, food and beverage companies, waste management companies, and municipality and government agencies around the world. Off-road, our potential customers include mining, material handling and port equipment manufacturers and operators. TheseInitial strategic customer groups generallyoften employ a ‘back-to-base’ model where their vehicles return to a central base or depot between operations, thereby allowing operators to have fueling independence as the necessary hydrogen can be produced locally at or proximate to the central base and dispensed at optimally-configured hydrogen refueling stations. Our fuel cell technologies are also compatible with light commercial vehicles among other applications. Hyzon plans tomay expand its range of products and hydrogen solutions ifas the transportation sector increasingly adopts hydrogen powerpropulsion and investments are made in hydrogen production and related infrastructure in accordance with our expectations.

In addition, we perform integration for rail and aviation customers and plan to expand our integration activities across maritimerail, aviation, mobile power and other applications in the future. We expect the opportunities in these sectors to continue to expand with the rapid technological advances in hydrogen-poweredhydrogen fuel cells and the increasing investments in hydrogen production, storage and refueling infrastructure around the world.

Fuel and Infrastructure

Our hydrogen supply infrastructure business is focused on building and fostering a clean hydrogen supply ecosystem with leading partners from feedstock through hydrogen production, dispensing and financing. We collaborate with strategic partners on development, construction, operation, and ownership of hydrogen production facilities and refueling stations in each major region of our operations, which intendswe intend to complement our back-to-base model and near-term fleet deployment. On July 29, 2021, the Company entered into a Master Hub Agreement with Raven SR, LLC (“Raven SR”) whereby Raven SR granted to the Company a right of first refusal to co-invest in up to 100 of Raven SR’s first 200 solid waste-to-hydrogen production hubs, and up to 150 of Raven SR’s gas-to-hydrogen production hubs across the United States on a hub-by-hub basis. In connection with this agreement, Hyzon invested $2.5 million on July 30, 2021, to acquire a minority interest in Raven SR. We expect near-term realization of the first waste-to-hydrogen production hub constructed by Raven SR coming online in Richmond, CA, with 5 tons per day of zero Carbon Intensity green hydrogen available for our near-term back-to-base fleets at diesel parity, in 2022.

Business Combination

On February 8, 2021, Legacy Hyzon, now Hyzon Motors USA Inc. (“Legacy Hyzon”) entered into the Business Combination Agreement and Plan of Reorganization (the “Business Combination”) with DCRB and Merger Sub pursuant to which Merger Sub merged with and into Legacy Hyzon, with Legacy Hyzon surviving the merger as a wholly owned subsidiary of DCRB. The transaction closed on July 16, 2021. Following the close of the business combination, DCRB has been named Hyzon Motors Inc., began trading on Nasdaq, and its common stock and warrants trade under the symbols “HYZN” and “HYZNW”, respectively. The Business Combination generated proceeds of approximately $509.0 million cash, net of transaction costs allocated to equity and redemptions by DCRB’s public stockholders. This includes an aggregate of $355 million of gross proceeds from the PIPE Financing at $10.00 per PIPE Share. Hyzon’s cash on hand after giving effect to this transaction, including transaction costs and expenses, is expected to be used for general corporate
34

Table of Contents
purposes, including developing infrastructure and supply chain, acquiring and leasing equipment for manufacturing, and investing in research and development.

COVID-19 Pandemic
The COVID-19 pandemic is currently impacting countries, communities, supply chains, and the global financial markets. Governments have imposed laws requiring social distancing, travel restrictions, shutdowns of businesses and quarantines, among others, and these laws may limit our ability to meet with potential customers or partners, or affect the ability of our personnel, suppliers, partners and customers to operate in the ordinary course of business. Although the economy has begun to recover, the severity and duration of the related global economic crisis is not fully known. The COVID-19 pandemic is expected to continue to have residual negative impacts, in particular the supply chain continues to face disruptions. Rebounding demand in key components challenge the supply base and supply chain with short notice and increasing volume levels. The supply constraints include overseas freight congestion causing extended lead times, semiconductor allocation, other raw/component material shortages and supplier staffing challenges.

The COVID-19 pandemic and measures to prevent its spread have had the following impact on our business:

Our workforce. Employee health and safety is our priority. In response to COVID-19, we established new protocols to help protect the health and safety of our workforce. We will continue to stay up-to-date and follow local, CDC, or WHO guidelines regarding safe work environment requirements.
Operations and Supply Chain. We continue to experience some delays in our supply chains which may temporarily limit our ability to outfit vehicles and fuel cell systems with key components. However, our global footprint has allowed us to leverage our strategic partnerships and to meet customer demands for zero emission heavy commercial vehicles despite these challenges. In the future, we may experience supply chain disruptions from related or third-party suppliers and any such supply chain disruptions could cause delays in our development and delivery timelines. We continue to monitor the situation for any potential adverse impacts and execute appropriate countermeasures, where possible.

While we have experienced some operational challenges, the long-term implications of the COVID-19 pandemic on our workforce, operations and supply chain, as well as demand remain uncertain. These factors may in turn have a material adverse effect on our results of operations, financial position, and cash flows.
deployment opportunities.

Key Trends and Uncertainties

We believe that our performance and future success dependsdepend on several factors that present significant opportunities for us but also pose risks and challenges, including those discussed below and in the section entitled “RiskRisk Factors — Risks Related to Hyzon” included in our amended Annual Report filed on Form 10-K/A for the Proxy of DCRB filed with SEC on June 21,year ended December 31, 2021.

Commercial Launch of Hyzon-branded commercial vehicles and other hydrogen solutions

OurWe reported negligible revenue and $2.9 million of revenue from the sale of hydrogen fuel cell systems in the United States, FCEVs in China, and retrofit services in Europe for the three and six months ended June 30, 2022, respectively.
22

Table of Contents
However, our business model has yet to be tested.proven. Prior to full commercialization of our commercial vehicle business at scale, we must complete the construction of required manufacturing facilities and achieve research and development milestones. We must establish and operate facilities capable of producing our hydrogen fuel cell systems or assemblingand leverage 3rd party vehicle manufacturers to assemble our hydrogen-powered commercial vehicles in appropriate volumes and at competitive costs.

Until we can generate sufficient additional revenue from our commercial vehicle business, we expect to finance our operations through equity and/or debt financings.financing. The amount and timing of our future funding requirements will depend on many factors, including the pace and results of our development efforts. We expect that any delays in the successful completion of our manufacturing facilities, availability of critical parts, and/or validation and testing will impact our ability to generate revenue.

Hydrogen Production & Supply Infrastructure

We continue to develop an end-to-end hydrogen ecosystem delivery model, with a partner-driven approach to design, build, own &and operate hydrogen production hubs and downstream dispensing infrastructure expected to provide zero-to-
35

Table of Contents
negativezero-to-negative carbon intensity hydrogen at below diesel-parity cost structures supporting Hyzon vehicle fleet deployments. We intend to continue forming additional partnerships across the full hydrogen feedstock, production &and dispensing lifecyclevalue chain in each major region in which we operate, that will be designed to ensure that the hydrogen fuel required is available at the cost and carbon intensity requirements to drive fleet conversions to Hyzon hydrogen fuel cell commercial vehicles. GivenFCEVs. Because we have a partner-driven approach, we are naturally reliant upon our partners’ performance in fulfilling the obligations that we depend on for delivery of each segment of that value chain. Additionally, consistent with other construction projects, there are risks related to realized construction cost and schedule that can impact final cost to produce and deliver hydrogen and timing of that delivery, along with the availability of feedstock near our vehicle fleet deployments. We intend to manage these risks by partnering with high quality and high performing partners with a track record of timely delivery and instituting commercial agreements to drive down construction cost and achieve on-time schedulescheduled performance.

Continued Investment in Innovation

We believe that we are the industry-leading hydrogen technology company with the most efficient and reliable fuel cell powertrain technologies and an unmatched product and service offering. Our financial performance will be significantly dependent on our ability to maintain this leading position. We expect to incur substantial and increasing research and development expenses and stock-based compensation expenses as a result. We dedicate significant resources towards research and development and invest heavily in recruiting talent, especially for vehicle design, vehicle software, fuel cell system, and electric powertrain engineers.powertrain. We will continue to recruit and retain talented engineerspersonnel to grow our strength in our core technologies. We expect to incur additional stock-based compensation expenses as we support our growth and status as a publicly traded company. We expect our strategic focus on innovation will further solidify our leadership position.

Customer Demand

We have received significant interest in our commercial vehicles and are able to convert non-binding letters of intent or memoranda of understanding into binding orders or sales. However, while we are continually seeking to expand our customer base,base; however, we depend on a few major customers and we expect this will continue for the next several years. AsThese customers will mostly employ a back-to-base model in the early adoption phase of September 30, 2021, Hyzon has received orders fromFCEVs. Vehicles will return to a central “base” between operations, allowing them to refuel onsite and/or nearby, where hydrogen can be produced locally at or proximate to the central base. While we focus on back-to-base or regional customers, in an aggregate value of approximately $14.6 million from companieswe expect to expand our target customer focus to include longer-haul truck and bus segments, additional vehicle classes, mobile power, and incremental mobility applications (e.g., rail, aviation) for customers around the world, and Hyzon’s customers have paid $7.8 million in deposits with respect to such orders.world.

Supplier Relationships

We also depend on third parties, including our majority beneficial shareholder and parent company Horizon for supply of key inputs and components for our products, such as fuel cells and automotive parts. We intend to negotiate potential relationships with industry-leading original equipment manufacturers (“OEMs”)OEMs to supply chassis for our Hyzon-branded vehicles but do not yet have any binding agreements and there is no guarantee that definitive agreements will be reached. SuchEven if we reach such agreements, such suppliers, including Horizon, may be unable to deliver the inputs and components necessary for us to produce our hydrogen-powered commercial vehicles or hydrogen fuel cell systems at prices, volumes, and specifications acceptable to us. If we are unable to source required inputs and other components from third parties on acceptable terms, it could have a material adverse effect on our business and results of operations.
23


Table of Contents
The automotive industry continues to face many supply chain disruption.disruptions. We are experiencing increases in both the cost of and time to receive of raw materials, such as semiconductors or chassis. Any such increase or supply interruptioninterruptions could materially negatively impact our business, prospects, financial condition, and operating results. Many of the parts for our products are sourced from suppliers in China, and the manufacturing situation in China remains uncertain.

Market Trends and Competition

The last ten years have seen the rapid development of alternative energy solutions in the transportation space. We believe this growth will continue to accelerate as increased product offerings, technological developments, reduced costs, additional supporting infrastructure, and increased global focus on climate goals drive broader adoption.

We believe that commercial vehicle operators, itsone of our initial target market,markets, will be driven towards hydrogen-powered commercial vehicles predominantly by the need to decarbonize activities, but also by the potential for lower total cost of ownership in comparison to the cost of ownership associated with traditional gasoline and diesel ICE vehicles.internal combustion engines. Our fuel cell
36

Table of Contents
technology can be deployed across a broad range of mobility applications, including on-road, off-road, rail, maritime and aviation.

The competitive landscape for our commercial vehicles ranges from vehicles relying on legacy ICEs,internal combustion engines, to extended range electric and battery electric engines, to other hydrogen fuel cell and alternative low-to-no carbon emission propulsion vehicles. Competitors include well established vehicle companies already deploying vehicles with internal fuel cell technology and other heavy vehicle companies that have announced their plans to offer fuel cell trucks in the future. We also face competition from other fuel cell manufacturers. We believe that our company is well positioned to capitalize on growth in demand for alternative low-to-no carbon emission propulsion vehicles due to the numerous benefits of hydrogen power, including hydrogen’s abundance and ability to be produced locally and the generally faster refueling times for hydrogen-powered commercial vehicles, as compared to electricity-powered vehicles. However, in order to successfully execute on our business plan, we must continue to innovate and convert successful research and development efforts into differentiated products, including new commercial vehicle models.

Our current and potential competitors have greater financial, technical, manufacturing, marketing and other resources. Our competitors may be able to deploy greater resources to the design, development, manufacturing, distribution, promotion, sales, marketing, and support of their internal combustion, alternative fuel and electric truck programs.

Regulatory Landscape

We operate in a highly regulated industry. The failure to comply with laws or regulations, including but limited to rules and regulations covering vehicle safety, emissions, dealerships, and distributors, could subject us to significant regulatory risk and changing laws and regulations and changing enforcement policies and priorities could adversely affect our business, prospects, financial condition and operating results. We may be also required to obtain and comply with the terms and conditions of multiple environmental permits, many of which are difficult and costly to obtain and could be subject to legal challenges. We depend on global customers and suppliers, and adverse changes in governmental policy or trade regimes could significantly impact the competitiveness of our products. Changes to applicable tax laws and regulations or exposure to additional income tax liabilities could affect our business and future profitability. See the section entitled “Information about Hyzon – Government Regulations”Regulations in our amended Annual Report filed on Form 10-K/A for the Proxy.
year ended December 31, 2021.

24

Table of Contents
Results of Operations

Three Months Ended September 30, 2021 and 2020The following table sets forth our historical operating results for the periods indicated (in thousands):

Hyzon was formed
Three Months Ended
June 30,
Six Months Ended
June 30,
20222021$ Change% Change20222021$ Change% Change
Revenue$46 $— $46 N/M$2,934 $— $2,934 N/M
Operating expense:
Cost of revenue1,370 — 1,370 N/M2,023 — 2,023 N/M
Research and development10,483 3,473 7,010 202 %17,419 4,099 13,320 325 %
Selling, general, and administrative20,065 5,800 14,265 246 %39,817 8,946 30,871 345 %
Total operating expenses31,918 9,273 22,645 244 %59,259 13,045 46,214 354 %
Loss from operations(31,872)(9,273)(22,599)244 %(56,325)(13,045)(43,280)332 %
Other income (expense):
Change in fair value of private placement warrant liability8,415 — 8,415 N/M9,938 — 9,938 N/M
Change in fair value of earnout liability66,096 — 66,096 N/M69,337 — 69,337 N/M
Gain (loss) on equity securities(2,448)— (2,448)N/M10,082 — 10,082 N/M
Foreign currency exchange loss and other expense(1,454)(30)(1,424)4747 %(2,604)(59)(2,545)4314 %
Interest income (expense), net54 (407)461 (113)%71 (4,995)5,066 (101)%
Total other income (expense)70,663 (437)71,100 (16270)%86,824 (5,054)91,878 (1818)%
Net income (loss) before income taxes38,791 (9,710)48,501 (499)%30,499 (18,099)48,598 (269)%
Income tax expense— — — N/M526 — 526 N/M
Net income (loss)$38,791 $(9,710)$48,501 (499)%$29,973 $(18,099)$48,072 (266)%
Less: Net loss attributable to noncontrolling interest(3,208)(289)(2,919)1010 %(5,503)(531)(4,972)936 %
Net income (loss) attributable to Hyzon$41,999 $(9,421)$51,420 (546)%$35,476 $(17,568)$53,044 (302)%

25

Table of Contents
Three Months Ended June 30, 2022 and commenced operations on January 21, 2020. As a result, we have a very limited operating history from inception and limited prior period comparable information available to be presented in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations of Hyzon.”2021

Revenue.Revenue We generated negligible revenue from retrofit services in Europe for the three months ended SeptemberJune 30, 2021 represents $0.1 million of2022 and we did not generate revenue from retrofit services performed by Hyzon Europe.for the three months ended June 30, 2021.

Operating Expenses. Operating expenses for the three months ended SeptemberJune 30, 20212022 were $46.8$31.9 million compared to $0.5$9.3 million for the three months ended SeptemberJune 30, 2020.2021. Operating expenses consist of cost of revenue, research and development expenses and selling, general and administrative expenses.

Cost of Revenue. Cost of revenue includes direct materials, labor costs, allocated overhead costs related to the manufacturing and retrofitting of hydrogen FCEVs, andfuel cell systems, estimated warranty costs.costs, and inventory write-downs. Cost of revenue for the three months ended SeptemberJune 30, 20212022 was $0.2 million.$1.4 million primarily related to cost provisions accrued for customer contract activities in Europe. We did not recordgenerate revenue for the three months ended June 30, 2021, or incur cost of revenue for the three months ended SeptemberJune 30, 2020.2021.

Research and Development Expenses.Research and development expenses represent costs incurred to support activities that advance the development of current and next generation hydrogen powered fuel cell systems, the design and development of ePowertrain,electric powertrain, and the integration of those systems into various mobility applications. Our research and development expenses consist primarily of employee-related personnel expenses, prototype materials and tooling, design expenses, consulting and contractor costs and an allocated portion of overhead costs.

Research and development expenses were $4.0$10.5 million and $0.1$3.5 million infor the three months ended SeptemberJune 30, 20212022 and September 30, 2020,2021, respectively. The increase was primarily due to $3.0$3.6 million in higher personnel costs, which were incurred in developing
37

Table of Contents
order to enhance our research and development expertise in vehicle design, vehicle software, fuel cell system, and electric powertrain. The remaining increase of $3.4 million is for our global customer base.materials used in research and development to further develop current and next generation hydrogen powered fuel cell systems, to design and develop an electric powertrain, and to integrate those systems into various mobility applications. We expect research and development expenses to continue to increase significantly and become a larger percentage of our operating expenses going forward as we build out our research facilities and expand headcount to advance our development of current and next generation hydrogen powered fuel cell systems, the design and development of ePowertrain, and the integration of those systems into various mobility applications.organization.

Selling, General, and Administrative Expenses. Selling expenses consist primarily of employee-related costs for individuals working in our sales and marketing departments, third partythird-party commissions, and related outreach activities. General and administrative expenses consist primarily of personnel-related expenses associated with our executive, finance, legal, information technology and human resources functions, as well as professional fees for legal, audit, accounting and other consulting services, and an allocated portion of overhead costs.

Selling, general, and administrative expenses were $42.7$20.1 million and $0.4$5.8 million infor the three months ended SeptemberJune 30, 20212022 and September 30, 2020,2021, respectively. The increase is comprised of $27.7was primarily due to $3.1 million related to stock compensation expense, $13.4in higher legal, accounting and consulting fees, $3.3 million of which is triggered by a key executive retirement arrangement (see Note 13. Stock-based Compensation Plans) and $14.0 million relates to earnout equity awards pursuant to the Business Combination (see Note 4. Business Combination). Salaryin higher salary and related expenses, were $3.3$3.2 million in the three months ended September 30, 2021 compared to $0.3higher insurance expense and $1.3 million in the three months ended September 30, 2020. Thehigher stock compensation expense. In addition, we incurred an additional increase of approximately $11.6$2.4 million in IT, rent, travel and other office related expenses to support business growth. We incurred greater selling, general, and administrative expense was due to building out the Company’s corporate infrastructure and legal and accounting costs associated with the Business Combination for the three months ended SeptemberJune 30, 2021 compared2022, as the Company continues to $0.4 million in the three months ended September 30, 2020. We also continue to incur increased expenses,build out its corporate infrastructure, including accounting, audit, legal, regulatory and tax-related services associated with maintaining compliance with exchange listingservices. The increase in selling, general and SEC requirements;administrative costs also resulted from increased director and officer insurance costs; andcosts, investor and public relations costs.

Change in Fair Value. Change in fair value represents non-cash gains or losses in estimated fair values of the private placement warrant liability, earnout liability, and investments in equity securities. Private placement warrant and earnout liabilities required to beare remeasured at each balance sheet date. ChangeEquity securities are remeasured when there is an observable price adjustment in an orderly transaction for an identical or similar investment in the same investee entity. Changes in estimated fair valuevalues of private placement warrant liability, earnout liability, and earnout liabilitiesinvestments in equity securities for the three months ended SeptemberJune 30, 2021,2022, were $7.6$8.4 million, $66.1 million, and $73.4$2.4 million, gains, respectively. The $2.4 million decrease in equity securities represents the impairment of NRG. There were no equivalent instruments requiring fair value remeasurement duringfor the three months ended SeptemberJune 30, 2020.2021.

Foreign Currency Exchange Gain (Loss).Loss and Other Expense. Foreign currency exchange gain (loss)loss represents exchange rate gains and losses related to all transactions denominated in a currency other than our or our subsidiary’s functional currencies. Foreign currency exchange loss was $0.1$1.5 million infor the three months ended SeptemberJune 30, 20212022, compared to negligible expense infor the three months ended SeptemberJune 30, 2020,2021, as there were few transactions in foreign currencies in the prior period. We expect the volume of foreign currency transactions to grow significantly in the future as we continue to expand our geographic footprint.

26

Table of Contents
Interest Expense,Income (Expense), net. Interest expense, netincome was $0.3$0.1 million infor the three months ended SeptemberJune 30, 2021,2022, compared to negligibleinterest expense of $0.4 million for the three months ended June 30, 2021. Interest expense in the three months ended SeptemberJune 30, 2020. Interest expense2021, relates primarily to the convertible debt issued in February 2021 and is comprised primarily offrom changes in the fair value of thean embedded derivative associated with the automatic conversion provision of the convertible note.notes. Upon close of the Business Combination in July 2021, the convertible debt and accrued interest converted into shares of common stock of the Company (see Note 4. Business Combination).Company. There was no debt outstanding during the three months ended SeptemberJune 30, 2020.2022.

Income Tax Expense. We had no income tax expense for the three months ended June 30, 2022 and 2021.

Net Income (Loss)Loss Attributable to Noncontrolling Interests. Net income (loss)loss attributable to noncontrolling interests represents results attributable to third parties in our operating subsidiaries. Net income (loss)loss is generally allocated based on such ownership interests held by third parties with respect to each of these entities.

Net loss attributable to noncontrolling interests was $0.8$3.2 million and $0.3 million for the three months ended SeptemberJune 30, 2022 and 2021, compared to zero in the three months ended September 30, 2020.respectively. The change in the comparative periods is the result of increased activities in our entering intoNetherlands joint venture and the creation of a joint venture agreement with Holthausen to establish a venture in the NetherlandsFoshan, China in October of 2020.2021.
Nine
Six Months Ended SeptemberJune 30, 20212022 and Period from January 21, 2020 (Inception) to September 30, 20202021

Revenue. Revenue for the ninesix months ended SeptemberJune 30, 20212022 was $2.9 million, and represents $0.1 millionsales of revenue fromfuel cell systems in the United States, FCEVs in China, and retrofit services performed by Hyzonin Europe. We did not generate revenue for the six months ended June 30, 2021.
38

Table of Contents

Operating Expense.Expenses. Operating expenses for the ninesix months ended SeptemberJune 30, 20212022 were $59.9$59.3 million compared to $0.8$13.0 million for the period from January 21, 2020 (Inception) to Septembersix months ended June 30, 2020.2021. Operating expenses consist of cost of revenue, research and development expenses and selling, general and administrative expenses.

Cost of Revenue. Cost of revenue includes direct materials, labor costs, allocated overhead costs related to the manufacturing and retrofitting of hydrogen FCEVs, fuel cell systems, estimated warranty costs, and inventory write-downs. Cost of revenue for the ninesix months ended SeptemberJune 30, 2022 was $2.0 million primarily related to cost provisions accrued for customer contract activities in Europe. The total cost of FCEVs delivered to the customer in China was recorded within Cost of revenue in the Consolidated Statements of Operations and Comprehensive Income (Loss) in 2021 since control of such FCEVs was $0.2 million.transferred to the customer prior to December 31, 2021. We did not recordgenerate revenue for the six months ended June 30, 2021, or incur cost of revenue for the period from January 21, 2020 (Inception) to Septembersix months ended June 30, 2020.2021.

Research and Development Expenses. Research and development expenses were $8.1 million and $0.2 million inrepresent costs incurred to support activities that advance the nine months ended September 30, 2021 and the period from January 21, 2020 (Inception) to September 30, 2020, respectively. The increase was primarily due to $5.4 million in higher personnel costs in developing our research and development expertise for our global customer base. We expect research and development expenses to increase significantly and become a larger percentage of our operating expenses going forward as we build out our research facilities and expand headcount to advance our development of current and next generation hydrogen powered fuel cell systems, and the design and development of ePowertrain,electric powertrain, and the integration of those systems into various mobility applications. Our research and development expenses consist primarily of employee-related personnel expenses, prototype materials and tooling, design expenses, consulting and contractor costs and an allocated portion of overhead costs.

Research and development expenses were $17.4 million and $4.1 million in the six months ended June 30, 2022 and 2021, respectively. The increase was primarily due to $7.1 million in higher personnel costs, which were incurred in order to enhance our research and development expertise in vehicle design, vehicle software, fuel cell system, and electric powertrain. The remaining increase of $6.2 million is for materials used in research and development to further develop current and next generation hydrogen powered fuel cell systems, to design and develop an electric powertrain, and to integrate those systems into various mobility applications. We expect research and development expenses to continue to increase significantly going forward as we build out our research facilities and organization.

Selling, General, and Administrative Expenses. Selling expenses consist primarily of employee-related costs for individuals working in our sales and marketing departments, third-party commissions, and related outreach activities. General and administrative expenses consist primarily of personnel-related expenses associated with our executive, finance, legal, information technology and human resources functions, as well as professional fees for legal, audit, accounting and other consulting services, and an allocated portion of overhead costs.

Selling, general, and administrative expenses were $51.6$39.8 million and $0.7$8.9 million in the ninesix months ended SeptemberJune 30, 20212022 and the period from January 21, 2020 (Inception) to September 30, 2020,2021, respectively. The increase is comprised of $28.1was primarily due to $8.2 million related to stock compensation expense, $13.4in higher legal, accounting and consulting fees, $7.6 million of which is triggered by a key executive retirement arrangement (see Note 13. Stock-based Compensation Plans) and $14.0 million relates to earnout equity awards pursuant to the Business Combination (see Note 4. Business Combination). Salaryin higher salary and related expenses, were $5.7$5.8 million in the nine months ended September 30, 2021 compared to $0.5higher insurance expense and $2.2 million in the period ended September 30, 2020. The additional increasehigher stock
27

Table of approximately $17.6Contents
compensation expense. In addition, we incurred $4.4 million in Selling,IT, rent, travel and other office related expenses to support business growth. We incurred greater selling, general, and administrative expense was due to building out the Company’s corporate infrastructure and legal and accounting costs associated with the Business Combination for the ninesix months ended SeptemberJune 30, 2021 compared2022 as the Company continues to $0.2 million for the period from January 21, 2020 (Inception) to September 30, 2020. We also expect to continue to incur increased expenses,build out its corporate infrastructure, including accounting, audit, legal, regulatory and tax-related services associated with maintaining compliance with exchange listing and SEC requirements;services. The increase also resulted from higher director and officer insurance costs; andcosts, investor and public relations costs.

Change in Fair Value.Change in fair value represents non-cash gains or losses in estimated fair valuevalues of the private placement warrant liability, earnout liability, and investments in equity securities. Private placement warrant and earnout liabilities are remeasured at each balance sheet date. Equity securities are remeasured when there is an observable price adjustment in an orderly transaction for an identical or similar investment in the same investee entity. Changes in estimated fair values of private placement warrant liability, earnout liability, and investments in equity securities for the ninesix months ended SeptemberJune 30, 2021,2022, were $7.6$9.9 million, $69.3 million, and $73.4$10.1 million, gains, respectively. The $10.1 million increase in the estimated fair value in investments in equity securities represents a $12.5 million gain related to our equity investment in Raven, offset by a $2.4 million impairment of our equity investment in NRG. There were no equivalent instruments requiring fair value remeasurement duringfor the period January 21, 2020 (Inception) to Septembersix months ended June 30, 2020.2021.

Foreign Currency Exchange Gain (Loss). Loss and Other Expense. Foreign currency exchange loss represents exchange rate gains and losses related to all transactions denominated in a currency other than our or our subsidiary’s functional currencies. Foreign currency exchange loss was $0.2$2.6 million for the six months ended June 30, 2022 compared to loss of $0.1 million in the ninesix months ended SeptemberJune 30, 2021, compared to negligible expense in the period January 21, 2020 (Inception) to September 30, 2020, as there were few transactions in foreign currencies in the prior period. We expect the volume of foreign currency transactions to grow significantly in the future as we continue to expand our geographic footprint.

Interest Expense,Income (Expense), net.Interest expense, netincome was $5.2$0.1 million in the ninesix months ended SeptemberJune 30, 20212022, compared to negligibleinterest expense of $5.0 million in the six months ended June 30, 2021. Interest expense in the period January 21, 2020 (Inception) to Septembersix months ended June 30, 2020. Interest expense in 2021 relates primarily to the convertible debt issued in February 2021 and is comprised primarily offrom changes in the fair value of thean embedded derivative associated with the automatic conversion provision of the convertible note.notes. Upon close of the Business Combination in July 2021, the convertible debt and accrued interest converted into shares of common stock of the Company. There was no debt outstanding during the six months ended June 30, 2022.

Income Tax Expense. For the six months ended June 30, 2022, the Company (see Note 4. Business Combination). Interestrecorded a net discrete tax expense in 2020 relatesof $0.5 million primarily associated with the establishment of a deferred tax liability that is not expected to offset available deferred tax assets. The Company has cumulative net operating losses at the convertible debt issued on August 24, 2020federal and converted to 250,000 common shares on October 19, 2020 uponstate level and maintains a full valuation allowance against its net deferred tax assets. We had no income tax expense for the Company’s closing of Qualified Financing.six months ended June 30, 2021.

Net Income (Loss)Loss Attributable to Noncontrolling Interests. Net loss attributable to noncontrolling interests represents results attributable to third parties in our operating subsidiaries. Net loss is generally allocated based on such ownership interests held by third parties with respect to each of these entities.

Net loss attributable to noncontrolling interests was $1.3$5.5 million and $0.5 million for the ninesix months ended SeptemberJune 30, 2022 and 2021, compared to zero in the period from January 21, 2020 (Inception) to September 30, 2020.respectively. The change in the comparative periods is the result of increased activities in our entering intoNetherlands joint venture and the creation of a joint venture agreement with Holthausen to establish a venture in the NetherlandsFoshan, China in October of 2020.2021.

28

Table of Contents
Non-GAAP Financial Measures

In addition to our results determined in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), we believe the following non-GAAP measures are useful in evaluating our operational performance.
39

Table of Contents
We use the following non-GAAP financial information to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that non-GAAP financial information, when taken collectively, may be helpful to investors in assessing our operating performance.

EBITDA and Adjusted EBITDA

“EBITDA” is defined as net lossincome (loss) before interest income or expense, income tax expense or benefit, and depreciation and amortization. “Adjusted EBITDA” is defined as EBITDA adjusted for stock-based compensation expense, change in fair value of private placement warrant liability, change in fair value of earnout liability, gain (loss) on equity securities and other special items determined by management, if applicable. EBITDA and Adjusted EBITDA are intended as supplemental measures of our performance that are neither required by, nor presented in accordance with, U.S. GAAP. We believe that the use of EBITDA and Adjusted EBITDA provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing our financial measures with those of comparable companies, which may present similar non-GAAP financial measures to investors. However, you should be aware that when evaluating EBITDA and Adjusted EBITDA we may incur future expenses similar to those excluded when calculating these measures. In addition, our presentation of these measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. Our computation of EBITDA and Adjusted EBITDA may not be comparable to other similarly titled measures computed by other companies, because all companies may not calculate Adjusted EBITDA in the same fashion.

Because of these limitations, EBITDA and Adjusted EBITDA should not be considered in isolation or as a substitute for performance measures calculated in accordance with U.S. GAAP. We compensate for these limitations by relying primarily on our U.S. GAAP results and using EBITDA and Adjusted EBITDA on a supplemental basis. You should review the reconciliation of net income (loss) to EBITDA and Adjusted EBITDA below and not rely on any single financial measure to evaluate our business.

The following tables reconciletable reconciles net income (loss)loss to EBITDA and Adjusted EBITDA (in thousands):
Three Months Ended September 30,
20212020
Net income (loss)$33,845 $(556)
Interest expense, net254 15 
Income tax expense (benefit)— — 
Depreciation and amortization30275 
EBITDA$34,401 $(466)
Change in fair value of private placement warrant liability(7,614)— 
Change in fair value of earnout liability(73,359)— 
Stock-based compensation14,766 — 
Executive transition charges(1)
13,860 — 
Business combination transaction expenses(2)
3,404 — 
Regulatory and legal matters(3)
111 — 
Adjusted EBITDA$(14,431)$(466)

Three Months Ended
June 30,
Six Months Ended
June 30,
 2022 202120222021
Net income (loss)$38,791 $(9,710)$29,973 $(18,099)
Interest (income) expense, net(54)407 (71)4,995 
Income tax expense— — 526 — 
Depreciation and amortization702 240 1,606 369 
EBITDA$39,439 $(9,063)$32,034 $(12,735)
Adjusted for:
Change in fair value of private placement warrant liability(8,415)— (9,938)— 
Change in fair value of earnout liability(66,096)— (69,337)— 
Gain (loss) on equity securities2,448 — (10,082)— 
Stock-based compensation1,859 587 3,052 877 
Regulatory and legal matters (1)
2,773 — 5,503 — 
Adjusted EBITDA$(27,992)$(8,476)$(48,768)$(11,858)
(1)Executive transition charges include stock-based compensation costs of $13.4 million and salary expense of $0.5 million related to former CTO’s retirement.
(2)Transaction costs of $3.3 million attributable to the liability classified earnout shares and $0.1 million of write-off of debt issuance costs.
(3)Regulatory and legal matters include legal, advisory, and other professional service fees incurred in connection with the short-seller analyst article from September 2021, and investigations and litigation related thereto.

40
29

Table of Contents
Nine Months Ended
September 30, 2021
For the period
January 21, 2020
(Inception) –
September 30, 2020
Net income (loss)$15,746 $(854)
Interest expense, net5,249 20 
Income tax expense (benefit)— — 
Depreciation and amortization67199 
EBITDA$21,666 $(735)
Change in fair value of private placement warrant liability(7,614)— 
Change in fair value of earnout liability(73,359)— 
Stock-based compensation15,644 — 
Executive transition charges(1)
13,860 — 
Business combination transaction expenses(2)
3,404 — 
Regulatory and legal matters(3)
111 — 
Adjusted EBITDA$(26,288)$(735)
Liquidity

(1)Executive transition charges include stock-based compensation costsThe Company reported net income of $13.4$38.8 million and salary expense$30.0 million for the three and six months ended June 30, 2022, respectively. The Company incurred a net loss of $0.5$9.7 million related to former CTO’s retirement.
(2)Transaction costs of $3.3and $18.1 million attributable tofor the liability classified earnout sharesthree and $0.1six months ended June 30, 2021, respectively. Net cash used in operating activities was $68.9 million of write-off of debt issuance costs.
(3)Regulatory and legal matters include legal, advisory,$19.5 million for the six months ended June 30, 2022 and other professional service fees incurred in connection with the short-seller analyst article from September 2021, and investigations and litigation related thereto.

Liquidity and Capital Resources

respectively. As of SeptemberJune 30, 2021,2022, we had $498.0$363.9 million in unrestricted cash and cash equivalents and positive working capital of $510.8 million, and retained earnings of $2.8$405.3 million. The Business Combination closed on July 16, 2021, generated proceeds of approximately $509.0 million of cash, net of transaction costs and redemptions. We believe that our current cash balance will provide adequate liquidity during the 12-month period following September 30, 2021.from the issuance date of these unaudited interim consolidated financial statements.

Our future capital requirements will depend on many factors, including, but not limitedAs an early stage growth company, the Company expects to continue to incur net losses in the ratenear term. As the Company commenced its internal restructuring effort in 2022, the primary focuses are the advancement of our growth, our ability toits proprietary fuel cell technology and development and commercialization of single heavy duty commercial vehicle platform in each region by leveraging third party contracted manufacturers. Until the Company can generate sufficient revenue from commercial vehicleproduct sales, and leasesretrofit services or lease arrangements to cover operating expenses, working capital and capital expenditures, the Company will need to raise additional capital. The Company expects to fund cash needs through a combination of equity and debt financing, including lease securitization, strategic collaborations, and licensing arrangements. If the Company cannot raise additional funds when needed, our financial condition, business, prospects, and results of operations could be materially adversely affected.

These financial statements have been prepared by management in accordance with U.S. GAAP and this basis assumes that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. These financial statements do not include any adjustments that may result from the outcome of this uncertainty. As of the date of this Quarterly Report on Form 10-Q, management believes that the Company’s existing financial resources will be sufficient to execute its operating priorities for the next 12 months following the issuance date of these unaudited interim consolidated financial statements. As of March 31, 2023, unrestricted cash, cash equivalents, and short-term investments were approximately $210 million.

Short-Term Liquidity Requirements

As of the date of this filing, we believe our available liquidity and capital resources duewill be sufficient to changedcontinue to execute our business conditionsstrategy over at least the next twelve-month period. This business strategy includes completing the development and commercial launch of our three focus FCEV truck platforms, successfully delivering additional FCEV trucks to customers and expanding our contracted customer pipeline, significantly advancing the commercialization of our 200 kW fuel cell system and manufacturing facility in Bolingbrook, IL, USA including continuing pre-sales of prototype 200 kW fuel cell systems, active management of our cost structure through the detailed cost and cash management plan that has been developed and is already in execution, and strategic hiring of critical personnel to deliver the above mentioned programs.

We have considered and assessed our ability to continue as a going concern for at least the one year from the date of this filing. We have undertaken certain actions to improve our cost structure, cash utilization focus and strategic alignment along with our pathway to cash flow breakeven during the last two quarters of 2022 and the first quarter of 2023:

integrated our organization globally to drive efficiencies in all regions, including reprioritization of hiring plans;

eliminated research and development programs deemed not vital to fuel cell and vehicle platform commercialization;

significantly reduced the number of vehicle variants in development, focusing on three core vehicle platforms;

halted commercial vehicle deliveries in China and restructured the China operation to align with the revised global strategic and execution priorities, which included a staff reduction of 17 employees;

conducted multiple divestitures to monetize non-core assets or contracts and acquired 100% ownership of Hyzon Europe to drive further operational efficiencies in our European operation;

30

Table of Contents
identified optimizations in our business model that further reduce the working capital requirements for our fuel cell system manufacturing and vehicle assembling business.

However, actual results could vary materially and negatively as a result of a number of factors, including:

our ability to manage the costs of manufacturing and servicing the FCEV trucks;

revenue received from sales of our FCEV trucks and 200 kW fuel cell systems;

the costs of expanding and maintaining our fuel cell manufacturing facility and equipment;

our warranty claims experience should actual warranty claims differ significantly from estimates;

the scope, progress, results, costs, timing and outcomes of the commercial development of our FCEV truck customer pipeline and conversion to contracts and deliveries;

the timing and the costs involved in bringing our vehicles and 200 kW fuel cell systems to market;

the costs of maintaining, expanding and protecting our intellectual property portfolio, including potential litigation costs and liabilities;

the timely assembly of, delivery to customers and performance of our FCEV trucks and 200 kW fuel cell systems as it relates to receiving revenue and expanding contracted revenue pipeline with customers;

the costs of additional general and administrative personnel, including accounting and finance, legal and human resources, as well as costs related to litigation, investigations, or settlements;

other developments,risks discussed in the section entitled "Risk Factors."

Long-Term Liquidity Requirements

Until we can generate sufficient revenue from truck sales and leases and fuel cell sales to cover operating expenses, working capital and capital expenditures, we expect to fund cash needs through a combination of equity and debt financing, including supply chain challenges, disruptions due to COVID-19, competitive pressures,lease securitization, strategic collaborations, and regulatory developments, among other developments. Further, we may enter into future arrangements to acquire or invest in businesses, products, services, strategic partnerships, and technologies. As such, we may be required to seek additional equity and/or debt financing. To the extent thatlicensing arrangements. If we raise additional capital through the salefunds by issuing equity securities, dilution to stockholders may result. Any equity securities issued may also provide for rights, preferences or privileges senior to those of equity or convertibleholders of our common stock. If we raise funds by issuing debt securities, the ownership interestthese debt securities may have rights, preferences and privileges senior to those of holders of our stockholders will be diluted, and thecommon stock. The terms of thesedebt securities may include liquidation or other preferences that adversely affect the rights of common stockholders. The incurrence of indebtedness would result in increased fixed obligations andborrowings could result in operating covenants that would restrictimpose significant restrictions on our operations. If we raise funds through collaborations and licensing arrangements, we might be required to relinquish significant rights to our technologies or products, or grant licenses on terms that are unablenot favorable to maintain sufficientus. The credit market and financial resources,services industry have in the past, and may in the future, experience periods of upheaval that could impact the availability and cost of equity and debt financing.

While we intend to raise additional capital in the future, if adequate funds are not available, we will need to reevaluate our expansion plans or limit our research and development activities, which could have a material adverse impact on our business financial condition and results of operations may be materially and adversely affected.prospects.

Debt

As of SeptemberJune 30, 20212022 and December 31, 2022, we have no debt. The Convertible Notesconvertible notes and accrued interest in the comparative period, were converted to 5,022,052 shares of common stock upon close of the Business Combination.

4131

Table of Contents

Cash Flows
Six Months Ended
June 30,
 2022 2021
Net cash used in operating activities$(68,880)$(19,484)
Net cash used in investing activities(7,652)(9,032)
Net cash (used in) provided by financing activities(3,781)44,467 

Cash Flows for the nineSix Months Ended SeptemberJune 30, 20212022 and for the Period from January 21, 2020 (Inception) through SeptemberJune 30, 20202021

Cash Flows from Operating Activities

Net cash used in operating activities was $52.2$68.9 million for the ninesix months ended SeptemberJune 30, 2021,2022, as compared to negligible cash provided$19.5 million for the period from January 21, 2020 (Inception) through Septembersix months ended June 30, 2020.2021. The cash flows used in operating activities for the ninesix months ended SeptemberJune 30, 2021 was2022 were primarily driven by net income of $15.7$30.0 million and adjustedadjustments for certain non-cash items and changes in operating assets and liabilities. Non-cash gain adjustments primarily consisted of changes in fair value of the private placement warrant liability of $7.6$9.9 million, earnout liability of $69.3 million, and earnout liabilitiesequity securities of $73.4$12.5 million. These non-cash gain adjustments were partially offset by $29.0$3.1 million stock-based compensation expense, and $0.7$1.6 million in depreciation and amortization. amortization and $2.4 million in impairment of equity securities.

Changes in operating assets and liabilities were primarily driven by $25.3a decrease of $1.8 million in prepayments for vehicle inventory, production equipment, other supplier deposits and D&O insurance, and $12.0an increase of $19.0 million in inventory purchases. Thebalances, an increase in accrued liabilities of $4.4 million and a decrease in accounts receivable of $2.9 million. Net cash flows provided byused in operating activities for the period from January 21, 2020 (Inception) through Septembersix months ended June 30, 20202021 was primarily driven by recording a net loss of $0.9$18.1 million slightly outweighed byand adjustments for certain non-cash items and changes in operating assets and liabilities. Non-cash loss adjustments primarily consisted of noncash interest expense of $4.9 million. These non-cash loss adjustments were partially offset by $8.7 million increase for prepayments for vehicle inventory, and other supplier deposits and $3.3 million increase in payables and accrued liabilities.

Cash Flows from Investing Activities

Net cash used in investing activities was $17.6$7.7 million for the ninesix months ended SeptemberJune 30, 2021,2022, as compared to $0.1$9.0 million for the period from January 21, 2020 (Inception) through Septembersix months ended June 30, 2020.2021. The cash flows used in investing activities for the ninesix months ended SeptemberJune 30, 2022 were primarily driven by $7.7 million cash paid for property and equipment. The cash flows used in investing activities for the six months ended June 30, 2021 werewas primarily due to $7.2driven by $2.2 million inadvanced payments for capital expenditures as well as, $4.0and $6.7 million in machinerycash paid for property and equipment deposits to begin production of hydrogen fuel cell systems and assembly of hydrogen storage systems, and $4.9 million investments in equity securities of NRG and Raven SR. The $7.2 million in capital expenditures were comprised of approximately $2.3 million related to acquiring a facility near Rochester, NY, $3.0 million in machinery equipment and $1.9 million in R&D assets. There were no similar purchases or investments in the period January 21, 2020 (Inception) through September 30, 2020.equipment.

Cash Flows from Financing Activities

Net cash used in financing activities was $3.8 million for the six months ended June 30, 2022, as compared to $44.5 million net cash provided by financing activities was $554.2 million for the ninesix months ended SeptemberJune 30, 2021, as compared to $0.6 million2021. The cash flows used in financing activities for the period from January 21, 2020 (Inception) through Septembersix months ended June 30, 2020.2022 were driven primarily by a $3.1 million payment towards the Horizon IP Agreement. The cash flows provided by financing activities for the ninesix months ended SeptemberJune 30, 2021 was duewere driven primarily to $509.0 million in proceeds from the Business Combination, net of transaction costs allocated to equity and redemption andby $45.0 million in proceeds from issuance of convertible debt. The cash flows provided by financing activities for the period from January 21, 2020 (Inception) through September 30, 2020 was due primarily to $0.5 million in proceeds from issuance of convertible debt.notes.

Contractual Obligations and Commitments

Hyzon’s contractual obligations and other commitmentsFor the six months ended June 30, 2022, there were no material changes outside the ordinary course of business within the Contractual Obligations table as of September 30, 2021, include payments totaling $10.0 millionpreviously disclosed in our amended Annual Report filed on Form 10-K/A for the aggregate due in 2021 to JS Horizon and JS Powertrain, pursuant to the terms of the Horizon IP Agreement. Please see the section below entitled “Intellectual Property” for additional information concerning the Horizon IP Agreement. This liability is reported under Horizon license agreement payable on the Condensed Consolidated Balance Sheets as of September 30, 2021. Subsequent to September 30, 2021, $6.9 million was paid and the remainder is expected to be paid inyear ended December 31, 2021.

32

Table of Contents
Off-Balance Sheet Arrangements

We do not maintain any off-balance sheet arrangements, transactions, obligations or other relationships with unconsolidated entities that would be expected to have a material current or future effect upon our financial condition or results of operations.

42

Table of Contents
Critical Accounting Policies and Estimates

Our condensed consolidated financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted inThere have been no substantial changes to these estimates, or the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management’s applications of accounting policies. Certain policies are particularly important to the portrayal of our financial position and results of operations and require the application of significant judgment by management to determine appropriate assumptions to be used in certain estimates; as a result, they are subject to an inherent degree of uncertainty and are considered critical. Accordingly, we believe the following policies are the most critical to aid in fully understanding and evaluating our financial condition and results of operations.

Revenue

The Company accounts for revenue in accordance with ASC 606. Revenue is based on the amount of transaction price to which the Company is entitled, subject to the allocation of the transaction price to distinct performance obligations. The Company recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration for which the Company expects to receive in exchange for those goods or services. To determine revenue recognition, the Company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation.

When it determines it is not probable that it will collect all of the consideration to which it will be entitled under a customer contract, the Company concludes the contract existence criteria under ASC 606 are not met. In these cases, the Company recognizes revenue to the extent of consideration received provided the amounts are non-refundable, the Company has transferred control of the goods or services to which the consideration relates, the Company has stopped transferring goods or services, and there is no obligation to transfer additional services.

The Company recognizes the incremental costs of obtaining contracts, including commissions, as an expense when incurred as the contractual period of the Company's arrangements are expected to be one year or less. Amounts billed to customers related to shipping and handling are classified as revenue, and the Company has elected to recognize the costthem for freight and shipping when control over vehicles, parts, or accessories has transferred to the customer as an expense in cost of revenue.

Product Sales

The Company enters into sales contracts with customers for the purchase of the Company’s products and services including fuel cell systems, FCEVs, parts, product support, and other related services. The Company considers order confirmations or purchase orders, which in some cases are governed by master vehicle supply agreements, to be contracts with a customer. The Company recognizes revenue when it satisfies a performance obligation by transferring control of product(s) or service to a customer. On standard vehicle sales contracts, revenues are recognized at a point in time when customers obtain control of the vehicle, which among other indicators, is generally when transfer of title and risks and rewards of ownership of goods have passed and when the Company has a present right to payment. Provisions for warranties are made at the time of sale. Sales, value-added, and other taxes collected concurrent with revenue producing activities are excluded from revenue.

Payment terms for sales of FCEVs to certain customers have included installment billing terms to fund the Company’s working capital requirements. The Company does not adjust the transaction price for a significant financing component when the performance obligation is expected to be fulfilled within a year as the amount is not material.

In China, the Company has granted extended payment terms to customers, which resulted in the Company concluding collection of all of the consideration under the contract is not probable. As a result, the contract existence criteria is not met and revenue is recognized under the Alternative Method of Revenue Recognition, which may not be in the same period that control of the related goods is transferred to the customers. The Company does not include a right of return on its products other than rights related to standard warranty provisions that permit repair or replacement of defective goods.

43

Table of Contents
Retrofit Services

The Company also enters into contracts with customers to retrofit ICE vehicles to FCEVs. In general, the customer controls any work in process arising from the Company’s performance; and the Company has in effect agreed to sell its rights to the work as it performs on a continuous basis. Revenue from these contracts is generally recognized over time utilizing an input method. Under the input method, the extent of progress towards completion is measured based on the ratio of normal costs incurred to date to the total estimated costs at completion of the performance obligation. Unexpected amounts of wasted materials, labor or other resources are excluded from the cost-to-cost measure of progress. The Company believes that this method is the most accurate representation of the Company's performance, because it directly measures the value of the services transferred to the customer over time as the Company incurs costs on its contracts. Contract costs include all direct materials, labor, and indirect costs related to contract performance, which may include indirect labor, supplies, tools, repairs and depreciation costs. The amount of revenue recognized for these contracts in a period is dependent on our ability to estimate total contract costs. The Company continually evaluates its estimates of total contract costs based on available information and experience.

Share-based Compensation

We measure and recognize compensation expense for all stock options and restricted stock awards based on the estimated fair value of the award on the grant date. The fair value is recognized as expense over the requisite service period, which is generally the vesting period of the respective award, on a straight-line basis when the only condition to vesting is continued service. If vesting is subject to a market or performance condition, recognition is based on the derived service period of the award. Expense for awards with performance conditions is estimated and adjusted based upon the assessment of the probability that the performance condition will be met.

We use the Black-Scholes option pricing model to estimate the fair value of stock option awards with service and/or performance conditions. The Black-Scholes option pricing model requires management to make a number of assumptions, including the expected life of the option, the volatility of the underlying stock, the risk-free interest rate and expected dividends. The assumptions used in our Black-Scholes option-pricing model represent our best estimates at the time of grant. These estimates involve a number of variables, uncertainties and assumptions and the application of our judgment, as they are inherently subjective. If any assumptions change, our stock-based compensation expense could be materially different in the future.

These assumptions are estimated as follows:

Fair Value of Common Stock. The grant date fair value of our common stock utilized in the calculation of share-based compensation was determined using valuation methodologies which utilize certain assumptions, including observations of comparable equity values and transactions, probability weighting of events, time to liquidation, a risk-adjusted interest rate, and assumptions regarding our projected future cash flows and growth potential.

Expected Term. The expected term represents the period that our stock options are expected to be outstanding.

Expected Volatility. We determine the price volatility factor based on the historical volatilities of our publicly traded peer group as Hyzon does not have a long trading history for our common stock. Industry peers consist of several public companies in the automotive and energy storage industry that are similar to Hyzon in size, stage of life cycle, and financial leverage.

Risk-Free Interest Rate. The risk-free interest rate was based on U.S. Treasury zero-coupon securities with maturities consistent with the estimated expected term.

Expected Dividend Yield. We have not paid dividends on our common stock nor do we expect to pay dividends in the foreseeable future.

44

Table of Contents
Warrant Liabilities

We account for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

We account for the Public Warrants as equity and account for the Private Placement Warrants, in connection with the Business Combination, as liabilities. In accordance with ASC 815, the Private Placement Warrants do not meet the criteria for equity classification and must be recorded as liabilities. As the Private Placement Warrants meet the definition of a derivative as contemplated in ASC 815, the warrants are measured at fair value at inception and remeasured at each reporting date.
We, with the assistance of third-party valuations, utilize the binominal lattice valuation model (“BLM”) to estimate the fair value of Private Placement Warrants at each reporting date. The application of the BLM utilizes significant unobservable assumptions, including volatility. Significant judgment is required in determining the expected volatility of our common stock.

Earnout Liability

The earnout shares with Legacy Hyzon’s common stockholders are accounted for as a liability. In accordance with ASC 815, the earnout shares with Legacy Hyzon common stockholders do not meet the criteria for equity classification and must be recorded as liabilities. Pursuant to ASC 805 initial measurement of these earnout shares are measured at its acquisition-date fair value and included as part of the consideration transferred in a business combination. As these earnout shares meet the definition of a derivative as contemplated in ASC 815, they are remeasured at each reporting date. Changes in fair value are recognized in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

The earnout shares to other holders of outstanding equity awards are accounted for in accordance with ASC 718, Stock Compensation, as they relate to stock-based compensation awards issued in exchange for service provided or to be provided to the Company. We recognized the earnout shares to other equity holders as separate and incremental awards from other equity holders’ underlying stock-based compensation awards. Upon the close of the Business Combination, we became contingently obligated to issue earnout shares if the vesting conditions were met. However, for unvested equity awards and where grant date was not established, we did not recognize any expense.

We, with the assistance of third-party valuations, utilize the Monte-Carlo valuation model to estimate the fair value of earnout shares at each reporting date. The application of the Monte-Carlo pricing model utilizes significant unobservable assumptions, including volatility. Significant judgment is required in determining the expected volatility of our common stock. Monte Carlo analysis simulates the future path of the Company’s stock price over the earnout period. The carrying amount of the liability may fluctuate significantly and actual amounts paid may be materially different from the liability’s estimated value.

Equity Valuations

For all periods prior to the consummation of the Business Combination, there was not a market for our equity. Accordingly, valuations of our equity instruments require the application of significant estimates, assumptions, and judgments. These valuations impact share-based compensation reported in our condensed consolidated financial statements. The following discussion provides additional details regarding the significant estimates, assumptions, and judgments that impact the determination of the fair values of share-based compensation awards and the common stock that comprises our capital structure. The following discussion also explains why these estimates, assumptions, and judgments could be subject to uncertainties and future variability.

45

Table of Contents
Common Stock Valuations

We use valuations of our common stock for various purposes, including, but not limited to, the determination of the exercise price of stock options and inclusion in the Black-Scholes option pricing model. As a privately held company, the lack of an active public market for our common stock requires our management and board of directors to exercise reasonable judgment and consider a number of factors in order to make the best estimate of fair value of our equity. As our capital structure consists of a single class of equity, Hyzon, with the assistance of a third-party valuation specialist, estimates the fair value of our total equity value using a combination of the comparable sales method (a market approach) and the excess earnings method (an income approach). Estimating our total equity value requires the application of significant judgment and assumptions. Factors considered in connection with estimating these values include:

Recent arms-length transactions involving the sale or transfer of our common stock;

Our historical financial results and future financial projections;

The market value of equity interests in substantially similar businesses, which equity interests can be valued through nondiscretionary, objective means;

The lack of marketability of our common stock;

The likelihood of achieving a liquidity event, such as the business combination, given prevailing market conditions;

Industry outlook; and

General economic outlook, including economic growth, inflation and unemployment, interest rate environment and global economic trends.

The fair value ultimately assigned to our common stock may take into account any number or combination of the various factors described above, based upon their applicability at the time of measurement. Determination of the fair value of our common stock also may involve the application of multiple valuation methodologies and approaches, with varying weighting applied to each methodology as of the grant date. Application of these approaches involves the use of estimates, judgment, and assumptions that are highly complex and subjective, such as those regarding our expected future revenue, expenses, and future cash flows; discount rates; market multiples; the selection of comparable companies; and the probability of possible future events. Changes in any or all of these estimates and assumptions or the relationships between those assumptions impact our valuations as of each valuation date and may have a material impact on the valuation of our common stock.

As of November 12, 2020, the estimated fair value of our common stock was $2.00 per share. In making this determination, we relied upon the previous Round A equity financing, which closed on November 12, 2020 as being the only reliable indication of fair value of our common stock before (and including) December 1, 2020. The price of the Round A capital raise was $2.00 per share of our common stock.

The estimated fair value of our common stock was $4.45 per share as of December 31, 2020. The increase in fair value was primarily due to our making progress and taking necessary steps to prepare for the Business Combination. The necessary steps undertaken to prepare for the Business Combination included meeting with DCRB and financial advisors, discussing timing expectations, negotiating a non-binding letter of intent and signing a binding exclusivity agreement between DCRB and Hyzon. As our ongoing negotiations related to the Business Combination reflected an increased likelihood of a near-term exit transaction and/or liquidity event, the valuation of our equity as of December 31, 2020 took into consideration the indicated equity value implied by the negotiations. While the December 31, 2020 valuation incorporated indicated equity values based upon traditional income and market approaches, consisting of the excess earnings method and comparable sales method. the valuation also incorporated the equity value implied by the business combination. Accordingly, the valuation applied the probability-weighted expected return method (PWERM) to weight the indicated equity value determined under the traditional income and market approaches and the equity value implied by our expected business combination with DCRB. Due to the proximity in time and observability, management placed the most significant weighting on the value as implied by the comparable sales method.

46

Table of Contents
The estimated fair value of our common stock was $9.90 per share as of June 30, 2021. The increase in fair value from December 31, 2020 to June 30, 2021 was primarily due to Hyzon executing a non-binding letter of intent with DCRB in January 2021 and signing a Business Combination Agreement with DCRB as well as issuing a convertible note payable in the amount of $45 million in February 2021. In addition, Hyzon made progress in procuring new orders from customers during the six months ended June 30, 2021.

As2022. For a full discussion of June 30, 2021, the estimated fair valuethese estimates and policies, see "Critical Accounting Policies and Estimates" in Item 7 of our common stock was $9.90 per share, which equates to an implied equity value of $1.0 billion. The primary difference betweenamended Annual Report filed on Form 10-K/A for the fair value derived on June 30, 2021 and the fair value implied by the Business Combination is that the fair value implied by the Business Combination is based only upon a scenario in which the parties complete the Business Combination and is not probability weighted, in contrast to the June 30, 2021 valuation, which considered multiple potential outcomes, some of which would have resulted in a lower value of our common stock than its implied transaction value.

Following the Business Combination with DCRB, it is no longer necessary for our management and its board of directors to estimate the fair value of our common stock, as the Class A common stock is traded in the public market.year ended December 31, 2021.

Emerging Growth Company Status

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. Hyzon elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, Hyzon, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard, until such time Hyzon is no longer considered to be an emerging growth company. At times, Hyzon may elect to early adopt a new or revised standard.

In addition, Hyzon intends to rely on the other exemptions and reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an emerging growth company, Hyzon intends to rely on such exemptions, Hyzon is not required to, among other things: (a) provide an auditor’s attestation report on Hyzon’s system of internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act; (b) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act; (c) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis); and (d) disclose certain executive compensation-related items such as the correlation between executive compensation and performance and comparisons of the Chief Executive Officer’s compensation to median employee compensation.

Hyzon will remain an emerging growth company under the JOBS Act until the earliest of (a) the last day of Hyzon’s first fiscal year following the fifth anniversary of the closing of DCRB’s initial public offering, (b) the last date of Hyzon’s fiscal year in which Hyzon has total annual gross revenue of at least $1.07 billion, (c) the date on which Hyzon is deemed to be a “large accelerated filer” under the rules of the SEC with at least $700.0 million of outstanding securities held by non-affiliates or (d) the date on which Hyzon has issued more than $1.0 billion in non-convertible debt securities during the previous three years.

33

Table of Contents
Material Transactions with Related Parties

Horizon IP Agreement

In January 2021, Hyzon entered into the Horizon IP Agreement with JS Horizon, part of the Horizon group of Companies, and in September 2021 JS Powertrain was an added party to the agreement. Pursuant to the agreement the parties convey to each other certain rights in intellectual property relating to Hyzon’s core fuel cell and mobility product technologies, under which Hyzon will pay JS Horizon and JS Powertrain a total fixed payment of $10.0 million in 2021. Subsequent to September 30, 2021, $6.9 million was paid and the remainder is expected to be paid in December 2021.

47

Table of Contents
Horizon Supply Agreement

In January 2021, Hyzon entered into a supply agreement with Jiangsuutilizes Horizon New Energy Technologies Co. Ltd, a wholly owned subsidiary of Horizon,and its subsidiaries to supply certain fuel cell components. During the three months ended March 31, 2021, the The Company made a deposit payment to Horizon in the amount of $5.0 million for long lead time components. This payment isin March 2021, and additional deposit payments totaling $4.4 million in 2022 to secure fuel cells and systems, which are included within Prepaid expenses in prepaid expenses as nonethe unaudited interim Consolidated Balance Sheets.

Certain employees of Horizon and its subsidiaries provide research and development, staff training, and administrative services to the Company. Based on an analysis of the components have yet been receivedcompensation costs incurred by Horizon and an estimate of the proportion of effort spent by such employees on each entity, an allocation of approximately $0.2 million and $0.5 million was recorded in the Company’s unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) related to such services for the three months ended June 30, 2022, and 2021, respectively. An allocation of approximately $0.5 million and $0.6 million was recorded in the Company’s unaudited interim Consolidated Statements of Operations and Comprehensive Income (Loss) related to such services for the six months ended June 30, 2022, and 2021, respectively.

The related party payable to Horizon and its subsidiaries is $0.1 million and $3.7 million as of SeptemberJune 30, 2021.2022 and December 31, 2021, respectively.

Holthausen and Affiliates

The Company entered into a joint venture agreement in October 2020 to create Hyzon Europe with Holthausen.Holthausen Clean Technology Investments B.V. (“Holthausen”). As Hyzon Europe builds out its production facilities, it relies on Holthausen and its affiliates for certain production resources that result in related party transactions. In addition, both companies rely on certain suppliers, including Horizon.

In JulyThe Company currently owns 50.5% of the equity interests of Hyzon Europe. On December 31, 2021, Hyzon executed a non-binding Letter of Intent (“LOI”) with Holthausen to increase its stake to 75% in Hyzon Europe. Concurrent with the signing of this LOI, a €1 million refundable deposit was paid to Holthausen, approximately $1.1 million in U.S. dollars (“USD”). This deposit is recorded within Prepaid expenses and other current assets in the unaudited interim Consolidated Balance Sheets.

Subsequently, in December 2022, the Company acquired the remaining 49.5% of the equity interests of Hyzon Europe from Holthausen. The Company now holds 100% ownership in Hyzon Europe. The Company paid €3.5 million (approximately $3.7 million in USD), in addition to €1.0 million (approximately $1.1 million in USD) paid in December 2021. As part of this transaction, the Company also transferred various inventory items to, and settled open related party balances with, Holthausen. In addition, the Company reassigned all of the assumed certain retrofit service contracts, fromincluding after-sales obligations, back to Holthausen Clean Technology B.V. The
For the three and six months ended June 30, 2022, respectively, the Company incurredpaid $0.1 million and $0.3 million to acquire these contracts.Carl Holthausen and Max Holthausen as managing directors of Hyzon Europe. For the three and six months ended June 30, 2021, the Company paid $0.2 million and $0.2 million, respectively.

As of SeptemberJune 30, 2021,2022, the Company has a net related party payable into Holthausen is $0.1 million. As of December 31, 2021, the amount of $0.8related party receivable from Holthausen is $0.3 million due to Holthausen..

Item 3.Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined in Rule 12b-2 under the Exchange Act. As a result, pursuant to Item 305(e) of Regulation S-K, we are not required to provide the information required by this Item.

34

Table of Contents
Item 4.    Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

The term disclosure controls and procedures means controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Interim Chief Financial Officer to allow timely decisions regarding required disclosure.

We do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all instances of fraud due to inherent limitation of internal controls. Because of these inherent limitations there is a risk that material misstatements will not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

Our Chief Executive Officer hasand Interim Chief Financial Officer have evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), as of SeptemberJune 30, 2021.2022. Based on such evaluation, our Chief Executive Officer hasand Interim Chief Financial Officer have concluded that as of SeptemberJune 30, 20212022 our disclosure controls and procedures were not effective because of the material weaknesses in internal control over financial reporting described below.

In light of the material weaknesses described below, our management has performed additional analyses, reconciliations, and other post-closing procedures and has concluded that, notwithstanding the ineffectiveness of our disclosure controls and procedures as well as material weaknesses in our internal control over financial reporting as of SeptemberJune 30, 2021,2022, the condensedunaudited interim consolidated financial statements for the periods covered by and included in this Form 10-Q/A10-Q fairly present, in all material respects, our financial position, results of operations and cash flows as of and for the periods presented in conformity with U.S. GAAP.

(b) Material Weaknesses in Internal Control over Financial Reporting

While preparing the Company’s condensedunaudited interim consolidated financial statements, our management identifiedconcluded that the following material weaknesses in internal control over financial reporting:reporting disclosed in our amended Annual Report filed on Form 10-K/A for the year ended December 31, 2021 are not fully remediated:

The Company did not demonstrate a commitment to attract, develop, and retain competent individuals in alignment with objectives and accordingly did not have sufficient qualified resources.

The Company did not have an effective risk assessment process that successfully identified and assessed risks of material misstatement to ensure controls were designed and implemented to respond to those risks.
48

Table of Contents

The Company did not have an effective internal information and communication process to ensure that relevant and reliable information was communicated on a timely basis across the organization, to enable financial personnel to effectively carry out their financial reporting and internal control roles and responsibilities.

The Company did not sufficiently establish structures, reporting lines and appropriate authorities and responsibilities in the pursuit of objectives.

As a consequence, the Company did not effectively design, implement and operate process-level control activities related to revenue recognition, complex accounting transactions, and the financial close process to mitigate risks to an acceptable level.

Those control deficiencies resulted in material misstatements that were identified and corrected in the condensed consolidated financial statements as of and for the periods ended September 30, 2021 primarily affecting revenue, cost of revenue, inventory, contract liabilities, and selling, general, and administrative expenses, as further described in Note 2. Restatement of Previously Issued Financial Statements to the condensed consolidated financial statements. Because there is a reasonable possibility that material misstatementmisstatements of the condensedunaudited interim consolidated financial statements will not be prevented or detected on a timely basis, we concluded that these deficiencies represent material weaknesses in our internal control over financial reporting and that our internal control over financial reporting was not effective as of SeptemberJune 30, 2021.2022.
35

Table of Contents

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatementmisstatements of our annual or interim financial statements will not be prevented or detected on a timely basis. These deficiencies could result in misstatements to our financial statements that would be material and would not be prevented or detected on a timely basis.

(c) Remediation Plan and Status

With oversight from the Audit Committee and input from the Board of Directors, management has begun designing and implementing changes in processes and controls to remediate the material weaknesses described above. Management and the Board of Directors, including the Audit Committee, are working to remediate the material weaknesses identified herein. While the Company expects to take other remedial actions, actions taken to date include:

appointed a new Chief Executive Officer and Interim Chief Financial Officer and created a new roleroles of President of International Operations;Operations, President of North America and Chief Operating Officer.

hired additional finance and accounting personnel over time to augment our accounting staff, including third-party resources with the appropriate technical accounting expertise;

engaged with external consultants with public company and technical accounting experience to facilitate accurate and timely accounting closes and to accurately prepare and review the unaudited interim consolidated financial statements and related footnote disclosures;

enhanced existingestablished a Disclosure Committee and implemented controls and procedures for the disclosure of Company data and information, as well as roles and responsibilities through afor formal review and sign off process; and

implemented a formal regional general manager financial statement review and certification process for each SEC filing.

In addition to the remedial actions taken to date, the Company is taking, or plans to take, the following actions to remediate the material weaknesses identified herein:

designing and implementing a comprehensive and continuous risk assessment process to identify and assess risks of material misstatements and to ensure that the impacted financial reporting processes and related internal controls are properly designed, maintained, and documented to respond to those risks in our financial reporting;

further developing and implementing formal policies, processes and documentation procedures relating to financial reporting, including revenue recognition and other complex accounting matters, and consulting with independent accounting experts and advisors;

49

Table of Contents
formalizing the design of the processes and controls related to sales of our products and services, as well as vendor contracting, fuel cell acceptance, transfer of control of our products to customers, tracking our vehicles' post-sale performance, and archiving documentation in a central system; and

completing ethics training globally and in addition, providing general public company periodic training for Company personnel, including on potential topics such as the responsibilities of a public company, the core values of the Company’s accounting and finance function, and best practices to implement those values.

36

Table of Contents
As we work to improve our internal control over financial reporting, we will report regularly to the Company’s Audit Committee on the progress and results of the remediation plan, including the identification, status, and resolution of internal control deficiencies. We may modify our remediation plan and may implement additional measures as we continue to review, optimize and enhance our financial reporting controls and procedures in the ordinary course. We will not be able to fully remediate these material weaknesses until these steps have been completed and have been operating effectively for a sufficient period of time. If we are unable to successfully remediate the material weakness,weaknesses, or if in the future, we identify further material weaknesses in our internal control over financial reporting, we may not detect errors on a timely basis and our unaudited interim consolidated financial statements may be materially misstated.

(d) Changes in Internal Control over Financial Reporting

There have not been any changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended SeptemberJune 30, 2021,2022, that have materially affected, or are reasonably likely to affect, our internal control over financial reporting.

37


Table of Contents
PART II – OTHER INFORMATION
Item 1.    Legal Proceedings
The information set forth under Note 11. Commitments and Contingencies, to our unaudited interim consolidated financial statements of this quarterly report on Form 10-Q is incorporated by reference in answer to this item. Such information is limited to certain recent developments.

Item 1A.    Risk Factors

As a result ofIn addition to the closing ofother information discussed in this report, please consider the Business Combination on July 16, 2021, the risk factors previously discloseddescribed in Part I, Item 1A of1A., “Risk Factors” in our Annual Report filed on Form 10-K/A10-K for the fiscal year ended December 31, 2020, no longer apply. For2021, as amended by Amendment No. 1 on Form 10-K/A, that could materially affect our business, financial condition or future results. There have not been any material changes to the risk factors relating to our business following the Business Combination, please refer to the section entitled “Risk Factorsdescribed in our Definitive Proxy Statement (file No. 001-39632) filed with2021 Form 10-K as amended, except for the SEC on June 21, 2021.additional risks noted below, but these are not the only risks facing our Company. Additional risk factorsrisks and uncertainties not presentlycurrently known to us or that we currently deem to be immaterial also may also impairadversely affect our business, financial condition or operating results.

Adverse developments affecting the financial services industry, including events or concerns involving liquidity, defaults or non-performance by financial institutions or transactional counterparties, could adversely affect our current and projected business operations, financial condition and results of operations.

Events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (“FDIC”) as receiver. Similarly, on March 12, 2023, Signature Bank and Silvergate Capital Corp. were each swept into receivership.

Our available cash and cash equivalents are held in accounts with or managed by financial institutions and consist of cash in our operating accounts and cash and cash equivalents. The amount of cash in our operating accounts exceeds the Federal Deposit Insurance Corporation insurance limits. While we monitor our accounts regularly and adjust our balances as appropriate, the valuation of or our access to these accounts could be negatively impacted if the underlying financial institutions fail or become subject to other adverse conditions in the financial markets. The operations of U.S. and global financial services institutions are interconnected and the performance and financial strength of specific institutions are subject to rapid change, the timing and extent of which cannot be known. To date, we have experienced no realized losses on, or lack of access to, our cash held in operating accounts or our invested cash or cash equivalents as a result of adverse conditions in the financial markets or with respect to financial institutions; however, we can provide no assurance that access to our cash held in operating accounts or our invested cash and cash equivalents will not be impacted by such adverse conditions in the future.

Although we assess our banking and customer relationships as we believe necessary or appropriate, our access to funding sources and other credit arrangements in amounts adequate to finance or capitalize our current and projected future business operations could be significantly impaired by factors that affect us, the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we have financial or business relationships but could also include factors involving financial markets or the financial services industry generally.

In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on acceptable terms or at all. Any decline in available funding or access to our cash and liquidity resources could, among other risks, adversely impact our ability to meet our operating expenses, financial obligations or fulfill our other obligations, result in breaches of our contractual obligations or result in violations of federal or state wage and hour laws. Any of these impacts, or any other impacts resulting from the factors described above or other related or similar factors not described above, could have material adverse impacts on our liquidity and our business, financial condition or results of operations. Other than as set forth below, there have been no material changes to the risk factors disclosed in our Definitive Proxy Statement.

We face risks and uncertainties related to litigation, regulatory actions and government investigations and inquiries.

We are subject to, and may become a party to, a variety of litigation, other claims, suits, regulatory actions and government investigations and inquiries. For example, two related putative securities class action lawsuits were filed against the Company, certain of its current officers and directors and certain officers and directors of DCRB between September 30, 2021, and October 13, 2021, in the U.S. District Court for the Western District of New York (Kauffmann v. Hyzon Motors Inc., et al. (No. 6:21-cv-06612-CJS); and Brennan v. Hyzon Motors Inc., et al. (No. 6:21-cv-06636-CJS)) asserting violations of federal securities laws. The complaints generally allege that the Company and individual defendants made materially false and misleading statements relating to the nature of its customer contracts, vehicle orders and sales and earnings projections, based on allegations in a report released on September 28, 2021 by Blue Orca Capital, an investment firm that indicated that it held a short position in our stock and made numerous allegations about the Company. The proceedings are subject to uncertainties inherent in the litigation process. We cannot predict the outcome of these matters or estimate the possible loss or range of possible loss, if any. We have incurred and may further incur substantial expenses as a result of regulatory and legal matters related to the Blue Orca Capital report and other similar research reports.

The outcome of litigation and other legal proceedings, including the other claims described under Legal Proceedings in Note 12. Commitments and Contingencies, to the condensed consolidated financial statements included elsewhere in this Current Report on Form 10-Q and incorporated by reference herein, are inherently uncertain and adverse judgments or settlements in some or all of these legal disputes may result in materially adverse monetary damages or injunctive relief against us. Any claims or litigation, even if fully indemnified or insured, could damage our reputation and make it more difficult to compete effectively or obtain adequate insurance in the future. The litigation and other legal proceedings described under Note 12 are subject to future developments and management’s view of these matters may change in the future.
5038

Table of Contents

We have identified material weaknesses in our internal control over financial reporting which, if not corrected, could affect the reliability of our condensedItem 2.    consolidated financial statements, affect our ability to record, process,Unregistered Sales of Equity Securities and report financial information accurately, impair our ability to prepare financial statements, negatively affect our relationships with suppliers and customers, negatively affect investor confidence, cause reputational harm, and have other adverse consequences. Additionally, failure to timely implement and maintain adequate financial, information technology and management processes, controls and procedures could result in further material weaknesses which could lead to errors in our financial reporting and adversely affect our business.Use of Proceeds

We are subject to the SEC’s internal control over financial reporting requirements and may become subject to the auditor attestation requirements asThere were no sales of the end of the 2022 fiscal year. Prior to the Business Combination, we were a special purpose acquisition company formedequity securities for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more operating businesses. As a result, previously existing internal controls are no longer applicable or comprehensive enough as of Septembersix months ended June 30, 2021, as our operations prior to2022 that were not registered under the Business Combination were insignificant compared to those of the consolidated entity post-Business Combination. The design of internal control over financial reporting for our business post-Business Combination has required and will continue to require significant time and resources from management and other personnel.Securities Act.

Effective internal controls are necessary for us to provide reliable and accurate financial reporting and financial statements for external purposes in accordance with generally accepted accounting principles. A failure to maintain effective internal control processes could lead to violations, unintentional or otherwise, of laws and regulations. As disclosed in the Explanatory Note and Part I, Item 4 “Controls and Procedures,” the Company has determined that there were material weaknesses in its internal control over financial reporting at the time of the preparation of its financial statements for the period ended September 30, 2021. As a result, the Company concluded that its internal control over financial reporting continued to be ineffective as of September 30, 2021. The Company is implementing remedial measures to address the material weaknesses and, while there can be no assurance that the efforts will be successful, the Company plans to remediate the material weaknesses as expeditiously as possible. If the Company is unable to remediate the material weaknesses, or is otherwise unable to maintain effective internal control over financial reporting or disclosure controls and procedures, its ability to record, process, and report financial information accurately, and to prepare financial statements within required time periods, is expected to be adversely affected. Litigation, government investigations, or regulatory enforcement actions arising out of such failure or alleged failure to comply with applicable laws and regulations could subject us to civil and criminal penalties that could materially and adversely affect our reputation, financial condition, and operating results. The material weaknesses, remediation efforts, and any related litigation or regulatory inquiries will require management attention and resources, and could result in unanticipated cost which could negatively affect our relationships with suppliers and customers, and may also negatively affect investor confidence in the Company’s financial statements, cause it reputational harm, and raise other risks to its operations. In addition, the costs and other effects of defending litigation or addressing regulatory enforcement actions against us may be difficult to determine and could adversely affect our financial condition and operating results.

Our restatement of certain of our previously issued financial statements may impose unanticipated costs, affect investor confidence, and cause reputational harm.

As discussed in the Explanatory Note and Part I, Item 1 Financial Statements Note 2. Restatement of Previously Issued Financial Statements to the condensed consolidated financial statements, this Form 10-Q/A amends the Original Filing to correct (1) the errors related to the recognition of revenue and associated balances for China FCEV transactions, and errors related to the recognition of revenue and associated balances for European FCEV transactions; and (2) the Evaluation of Disclosure Controls and Procedures included under Item 4. As a result, the Company has incurred, and may continue to incur, unanticipated costs in connection with or related to the Special Committee investigation and the Restatement, as well as any litigation or regulatory inquiries that may result and have resulted therefrom. In addition, the investigation, the Restatement, and related media coverage may negatively affect our relationships with suppliers and customers and may also negatively affect investor confidence in the accuracy of the Company’s financial disclosures and cause it reputational harm.
3.
Defaults Upon Senior Securities

None.

Item 4.Mine Safety Disclosures

Not applicable.

Item 5.Other Information

None.
51
39

Table of Contents
Item 6.    Exhibits
Exhibit
Number
Description
3.1
3.2
4.110.1#
10.110.2
10.2#
10.3#
10.4#
10.5#
10.6#10.3
31.1
31.2
32.1*
32.2*
101.INSInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
_________________________
*    This information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange ActAct.
#    Indicates management contract or compensatory arrangement.
Filed or furnished herewith.
52
40

Table of Contents
SIGNATURE

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Hyzon Motors Inc.
Date: March 14,May 1, 2023By:/s/ Parker Meeks
Name:Parker Meeks
Title:Chief Executive Officer
Date: May 1, 2023By:/s/ Jiajia Wu
Name:Jiajia Wu
Title:Interim Chief Financial Officer and Chief Accounting Officer
5341